can you suggest some project topics

Asking for Preferences

for m pharm(pharmacy practice)

Searching the Web

M Pharm pharmacy practice research project topics 2024 2025

Searching the Web

pharmacy practice postgraduate dissertation topics clinical pharmacy pharmacovigilance

Here are well-organized, research-worthy project topics for M. Pharm (Pharmacy Practice) - covering all major domains of the specialization:

Clinical Pharmacy & Patient Care

  1. Impact of clinical pharmacist interventions on drug-related problems in ICU/medicine wards
  2. Medication reconciliation at hospital admission/discharge - frequency and nature of discrepancies
  3. Assessment of pharmacist-led anticoagulation management clinics (warfarin/DOAC monitoring)
  4. Role of pharmacist in optimizing pain management in post-surgical patients
  5. Pharmaceutical care in chronic kidney disease (CKD) - drug dose adjustment assessment
  6. Clinical pharmacist's role in reducing length of hospital stay - a prospective interventional study

Pharmacovigilance & Drug Safety

  1. Spontaneous ADR reporting pattern at a tertiary care hospital - under-reporting analysis
  2. Causality and severity assessment of adverse drug reactions in oncology patients
  3. Drug-drug interaction prevalence in polypharmacy patients admitted to cardiology/medicine ward
  4. ADR monitoring and reporting in HIV/TB co-infected patients on HAART + anti-TB therapy
  5. Signal detection from pharmacovigilance data using WHO-UMC causality criteria

Medication Adherence & Patient Counseling

  1. Assessment of medication adherence in hypertension/diabetes patients using Morisky scale
  2. Impact of pharmacist-led patient counseling on glycemic control in Type 2 DM
  3. Medication adherence in psychiatric outpatients - barriers and pharmacist interventions
  4. Effect of pill organizers and reminder apps on adherence in elderly polypharmacy patients

Drug Utilization Studies (DUS)

  1. Drug utilization study of antibiotics in a surgical ward - WHO DDD methodology
  2. Prescribing pattern analysis using WHO prescribing indicators in a primary health centre
  3. Drug utilization review in pediatric patients - rationality assessment
  4. Study on use of proton pump inhibitors - appropriateness in hospitalized patients
  5. Utilization pattern of anti-diabetic drugs in a tertiary care outpatient setting

Medication Errors & Patient Safety

  1. Incidence, type, and severity of medication errors in a teaching hospital
  2. Prescribing errors in pediatric inpatients - identification and pharmacist interventions
  3. Near-miss medication errors in hospital pharmacy - root cause analysis
  4. Impact of pharmacist participation in ward rounds on prescribing errors

Pharmacoeconomics & Health Outcomes

  1. Cost-of-illness study of Type 2 diabetes mellitus in outpatient setting
  2. Pharmacoeconomic analysis of antibiotic stewardship program implementation
  3. Cost-effectiveness of pharmacist-managed chronic disease clinics vs. standard care
  4. Health-related quality of life (HRQoL) assessment in cancer or COPD patients using SF-36/EQ-5D

Antibiotic Stewardship

  1. Implementation and evaluation of antibiotic stewardship program in a hospital
  2. Assessment of antibiotic prescribing practices against standard treatment guidelines
  3. Carbapenem usage audit - appropriateness in ICU settings
  4. Knowledge, attitude and practice (KAP) of antimicrobial resistance among healthcare workers

Community & Social Pharmacy

  1. Assessment of self-medication practices among urban/rural populations
  2. Role of community pharmacists in managing minor ailments - a cross-sectional survey
  3. Over-the-counter (OTC) antibiotic dispensing practices in community pharmacies
  4. Knowledge and counseling practices of pharmacists regarding contraceptives

Emerging / High-Impact Topics (2025-26)

  1. Digital health tools (apps, telemedicine) in pharmacy practice - patient and pharmacist perspectives
  2. Artificial intelligence in clinical decision support - pharmacist attitudes and adoption
  3. Pharmacist's role in COVID-19 / post-COVID management and vaccine counseling
  4. Deprescribing inappropriate medications in elderly patients - pharmacist-led intervention
  5. Assessment of biosimilar prescribing practices and pharmacist awareness

Tips for Choosing Your Topic

  • Prospective interventional studies (e.g., patient counseling, ADR monitoring) are highly publishable and valued at M. Pharm level.
  • Drug utilization + prescribing pattern studies are feasible with hospital data and have strong publication scope.
  • Pharmacoeconomics topics are relatively novel in Indian/developing-country settings - good for standing out.
  • Align with your hospital's specialty (oncology, cardiology, nephrology) for easier data access and focused depth.
Would you like me to help narrow down to 2-3 specific topics, draft a study design, or suggest objectives for any of these?

hospital speciality

Asking for Preferences
Here are focused, publication-worthy M. Pharm (Pharmacy Practice) project topics for Cardiology:

Drug Utilization & Prescribing Pattern Studies

  1. Drug utilization study of antihypertensives in hypertensive inpatients/outpatients using WHO DDD methodology
  2. Prescribing pattern of antiplatelet agents in acute coronary syndrome (ACS) patients
  3. Assessment of statin prescribing practices and goal attainment (LDL targets) in coronary artery disease (CAD)
  4. Drug utilization review of anticoagulants (heparin, warfarin, DOACs) in atrial fibrillation patients
  5. Prescribing pattern analysis in heart failure - adherence to guideline-directed medical therapy (GDMT)

Medication Adherence Studies

  1. Assessment of medication adherence in hypertensive patients using Morisky Medication Adherence Scale (MMAS-8) and its determinants
  2. Adherence to dual antiplatelet therapy (DAPT) post-PCI/stent and clinical outcomes
  3. Impact of pharmacist counseling on medication adherence and blood pressure control - a prospective interventional study
  4. Factors influencing non-adherence to statin therapy in dyslipidemia patients

Drug-Related Problems (DRPs)

  1. Identification and assessment of drug-related problems in cardiac ICU patients using PCNE classification
  2. Prevalence of drug-drug interactions in polypharmacy cardiac patients - a cross-sectional study
  3. Clinical significance of potential drug interactions in patients on warfarin - impact of pharmacist intervention
  4. Assessment of inappropriate prescribing in elderly cardiac patients using Beers criteria / STOPP-START tool

Adverse Drug Reactions (ADR) & Pharmacovigilance

  1. Monitoring and reporting of ADRs to cardiovascular drugs (ACE inhibitors, statins, amiodarone, digoxin) in a cardiology ward
  2. Statin-induced myopathy surveillance - incidence, risk factors, and pharmacist reporting
  3. ADR profiling of antiarrhythmic drugs - a prospective observational study
  4. Causality and severity assessment of ADRs in cardiac patients using Naranjo and WHO-UMC scales

Clinical Pharmacist Interventions

  1. Impact of pharmacist-led medication review on drug-related problems in heart failure patients
  2. Pharmacist interventions in improving INR control in patients on warfarin therapy
  3. Role of clinical pharmacist in anticoagulation management clinic - safety and outcomes
  4. Pharmacist-driven hypertension management program - effect on blood pressure control and quality of life
  5. Assessment of pharmacist recommendations during cardiology ward rounds and acceptance rate by physicians

Pharmacoeconomics

  1. Cost-of-illness study of heart failure in a tertiary care cardiology unit
  2. Pharmacoeconomic analysis of thrombolytic therapy vs. primary PCI in STEMI patients
  3. Cost-effectiveness of generic vs. branded antihypertensives in a public hospital setting
  4. Direct medical costs associated with drug-related problems in cardiology inpatients

Patient Education & Quality of Life

  1. Assessment of patient knowledge, attitude and practice (KAP) regarding hypertension and its management
  2. Impact of pharmacist-led cardiac rehabilitation counseling on lifestyle modification and drug adherence
  3. Health-related quality of life (HRQoL) in heart failure patients using Minnesota Living with Heart Failure Questionnaire (MLHFQ)
  4. Assessment of patients' knowledge on anticoagulation therapy and impact of pharmacist education

Medication Safety & Errors

  1. Medication errors in cardiology ICU - incidence, type, and contributing factors
  2. High-alert medication safety assessment (heparin, digoxin, amiodarone) in a cardiac care unit
  3. Medication reconciliation at admission and discharge in cardiac inpatients - discrepancy analysis

Emerging / Trending Topics (2025-26)

  1. Assessment of SGLT2 inhibitor and GLP-1 agonist prescribing for cardiovascular risk reduction in diabetes patients
  2. Pharmacist's role in managing polypharmacy in chronic heart failure - deprescribing interventions
  3. Digital health and mHealth apps for cardiac medication management - patient awareness and pharmacist perspectives
  4. Evaluation of antibiotic prophylaxis practices in cardiac surgery - appropriateness and outcomes

Top 3 Recommendations (Easy to execute + highly publishable)

#TopicWhy it's good
1Pharmacist counseling intervention on adherence in hypertensionProspective, interventional, clear outcome measures
2Drug-related problems in cardiac ICU using PCNE classificationHigh clinical impact, good for publications
3Assessment of GDMT in heart failure patientsTopical, guideline-based, feasible with retrospective data

Would you like help with objectives, methodology, or a study design for any of these topics?

gynecology?

Here are focused M. Pharm (Pharmacy Practice) project topics for Gynecology & Obstetrics:

Drug Utilization & Prescribing Pattern Studies

  1. Drug utilization study in antenatal care (ANC) - pattern of iron, folic acid, calcium, and antibiotic prescribing
  2. Prescribing pattern of oxytocics and uterotonics in labour and delivery ward
  3. Drug utilization review in postpartum hemorrhage (PPH) management - adherence to WHO protocols
  4. Assessment of antibiotic prescribing in cesarean section - appropriateness and prophylaxis patterns
  5. Drug utilization study in gestational diabetes mellitus (GDM) - insulin vs. oral hypoglycemics

Medication Adherence

  1. Adherence to iron and folic acid supplementation in pregnant women and associated factors
  2. Compliance with antihypertensive therapy in pregnancy-induced hypertension (PIH) / preeclampsia
  3. Medication adherence in women with polycystic ovarian syndrome (PCOS) on metformin/OCP
  4. Impact of pharmacist counseling on adherence to antenatal supplements - interventional study

Adverse Drug Reactions & Pharmacovigilance

  1. Monitoring and reporting of ADRs to drugs used in obstetrics - oxytocin, magnesium sulfate, misoprostol
  2. ADR surveillance of hormonal contraceptives in family planning clinic
  3. Teratogenicity risk assessment - exposure to category C/D/X drugs during first trimester
  4. ADR profiling of drugs used in preeclampsia management - labetalol, nifedipine, magnesium sulfate

Drug-Related Problems (DRPs)

  1. Identification of drug-related problems in high-risk pregnancy patients using PCNE classification
  2. Potential drug interactions in polypharmacy obstetric patients - prevalence and clinical significance
  3. Assessment of inappropriate medication use in pregnancy - Hale's Lactation Risk/FDA category analysis
  4. Medication errors in obstetric wards - types, contributing factors, and pharmacist interventions

Clinical Pharmacist Interventions

  1. Impact of pharmacist-led counseling on management of nausea and vomiting of pregnancy (NVP)
  2. Role of clinical pharmacist in preeclampsia/eclampsia management - drug therapy optimization
  3. Pharmacist intervention in reducing medication errors in labor and delivery unit
  4. Assessment of pharmacist recommendations in gynecology ward rounds - type and acceptance rate

Patient Knowledge, Attitude & Practice (KAP)

  1. KAP study on use of oral contraceptive pills (OCPs) among women of reproductive age
  2. Assessment of women's knowledge on safe use of drugs during pregnancy and lactation
  3. Patient awareness of emergency contraception - knowledge gaps and pharmacist's counseling role
  4. KAP of self-medication practices in pregnant women - risks and prevalence

Pharmacoeconomics & Health Outcomes

  1. Cost-of-illness study of preeclampsia in a tertiary care setting
  2. Pharmacoeconomic comparison of misoprostol vs. oxytocin in PPH prevention
  3. Direct medical costs associated with gestational diabetes management
  4. Health-related quality of life (HRQoL) in women with PCOS using SF-36 questionnaire

Specific Disease/Condition-Based Studies

  1. Assessment of pharmacotherapy in PCOS - ovulation induction, metformin, hormonal therapy patterns
  2. Drug therapy evaluation in endometriosis - hormonal and analgesic use patterns
  3. Management of preterm labor - tocolytic drug use assessment and outcomes
  4. Evaluation of chemotherapy regimens in gynecological cancers (cervical, ovarian, endometrial) - safety monitoring
  5. Antifungal use pattern in vulvovaginal candidiasis - OTC vs. prescription analysis

Emerging Topics (2025-26)

  1. Pharmacist's role in reproductive health counseling - contraception, fertility, preconception care
  2. Assessment of knowledge and practice of pharmacists on drugs in breastfeeding
  3. Use of progesterone supplementation in threatened abortion - prescribing pattern and outcomes
  4. Digital health interventions for antenatal medication adherence - app-based reminders
  5. Evaluation of iron deficiency anemia treatment in pregnancy - IV vs. oral iron therapy outcomes

Top 3 Recommendations

#TopicWhy it's good
1Pharmacist counseling on antenatal supplement adherenceProspective, interventional, clear measurable outcomes, highly feasible
2Drug-related problems in high-risk pregnancy (PCNE)High clinical relevance, publishable, structured tool available
3KAP on OCP use among reproductive-age womenCross-sectional, easy data collection, strong public health relevance

Would you like help drafting aims & objectives, inclusion/exclusion criteria, or a methodology for any specific topic?

Create a comparison table of these 39 topics by feasibility

Here is the comparison table of all 39 Gynecology topics rated by feasibility:

Feasibility Rating Key

  • Data Access: How easily can data/patients be recruited?
  • Ethics Complexity: Simple (✅) = minimal hurdles | Complex (⚠️) = needs extra clearance
  • Time Required: Short (<6 months), Medium (6-9 months), Long (>9 months)
  • Overall Feasibility: ⭐⭐⭐ = High | ⭐⭐ = Moderate | ⭐ = Difficult

#TopicStudy TypeData AccessEthics ComplexityTime RequiredCostOverall Feasibility
1Drug utilization in antenatal care (ANC)Retrospective/Prospective✅ Easy - OPD records✅ SimpleShortLow⭐⭐⭐
2Prescribing pattern of oxytocics/uterotonicsRetrospective✅ Ward records✅ SimpleShortLow⭐⭐⭐
3Drug utilization in PPH managementRetrospective✅ Case sheets✅ SimpleShortLow⭐⭐⭐
4Antibiotic prescribing in C-sectionRetrospective✅ OT + ward records✅ SimpleShortLow⭐⭐⭐
5Drug utilization in gestational diabetes (GDM)Prospective/Retrospective✅ OPD + ward✅ SimpleMediumLow⭐⭐⭐
6Adherence to iron & folic acid in pregnancyCross-sectional/Interventional✅ ANC clinic patients✅ SimpleMediumLow⭐⭐⭐
7Antihypertensive adherence in PIH/preeclampsiaProspective observational✅ Ward + OPD✅ SimpleMediumLow⭐⭐⭐
8Adherence in PCOS on metformin/OCPCross-sectional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
9Pharmacist counseling impact on antenatal supplement adherenceProspective interventional✅ ANC clinic⚠️ Moderate (consent)MediumLow⭐⭐⭐
10ADR monitoring in obstetric drugsProspective observational✅ Ward patients✅ SimpleMediumLow⭐⭐⭐
11ADR surveillance of hormonal contraceptivesCross-sectional/Prospective✅ Family planning OPD✅ SimpleMediumLow⭐⭐⭐
12Teratogenicity risk - category C/D/X exposureRetrospective⚠️ Needs detailed records⚠️ ModerateMediumLow⭐⭐
13ADR profiling in preeclampsia managementProspective observational✅ Ward patients✅ SimpleMediumLow⭐⭐⭐
14Drug-related problems in high-risk pregnancy (PCNE)Prospective observational✅ High-risk OPD/ward⚠️ Moderate (consent)MediumLow⭐⭐⭐
15Drug interactions in polypharmacy obstetric patientsRetrospective/Prospective✅ Prescriptions/case sheets✅ SimpleShortLow⭐⭐⭐
16Inappropriate medication in pregnancy (FDA/Hale)Retrospective✅ Case records✅ SimpleShortLow⭐⭐⭐
17Medication errors in obstetric wardsProspective observational⚠️ Staff cooperation needed⚠️ ModerateMediumLow⭐⭐
18Pharmacist counseling in nausea/vomiting of pregnancyProspective interventional✅ ANC OPD⚠️ Moderate (consent)MediumLow⭐⭐⭐
19Pharmacist role in preeclampsia drug optimizationProspective interventional✅ Ward patients⚠️ ModerateMediumLow⭐⭐
20Pharmacist interventions reducing medication errors in L&DProspective interventional⚠️ Needs ward access⚠️ ModerateLongMedium⭐⭐
21Pharmacist recommendations in gynecology ward roundsProspective observational⚠️ Needs physician cooperation⚠️ ModerateMediumLow⭐⭐
22KAP on oral contraceptive pills (OCPs)Cross-sectional survey✅ OPD/community women✅ SimpleShortLow⭐⭐⭐
23Knowledge on drugs in pregnancy and lactationCross-sectional survey✅ ANC/postnatal patients✅ SimpleShortLow⭐⭐⭐
24Patient awareness of emergency contraceptionCross-sectional survey✅ OPD/community✅ SimpleShortLow⭐⭐⭐
25KAP of self-medication in pregnant womenCross-sectional survey✅ ANC OPD✅ SimpleShortLow⭐⭐⭐
26Cost-of-illness study of preeclampsiaRetrospective/Prospective✅ Hospital billing + records⚠️ ModerateMediumLow⭐⭐
27Pharmacoeconomic comparison - misoprostol vs. oxytocin in PPHRetrospective comparative✅ Ward records + billing✅ SimpleMediumLow⭐⭐⭐
28Direct medical costs in GDM managementRetrospective✅ Hospital billing✅ SimpleShortLow⭐⭐⭐
29HRQoL in PCOS women using SF-36Cross-sectional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
30Pharmacotherapy assessment in PCOSCross-sectional/Retrospective✅ OPD records✅ SimpleShortLow⭐⭐⭐
31Drug therapy in endometriosisRetrospective⚠️ Moderate - diagnosis confirmation✅ SimpleMediumLow⭐⭐
32Management of preterm labor - tocolytic useRetrospective/Prospective✅ Ward records✅ SimpleMediumLow⭐⭐⭐
33Chemotherapy regimens in gynecological cancersProspective observational⚠️ Oncology unit access needed⚠️ ModerateLongMedium⭐⭐
34Antifungal use in vulvovaginal candidiasisCross-sectional/Retrospective✅ OPD records/pharmacy✅ SimpleShortLow⭐⭐⭐
35Pharmacist role in reproductive health counselingCross-sectional/Interventional✅ OPD patients✅ SimpleMediumLow⭐⭐⭐
36Pharmacist knowledge on drugs in breastfeedingCross-sectional survey✅ Pharmacists as subjects✅ SimpleShortLow⭐⭐⭐
37Progesterone supplementation in threatened abortionRetrospective observational✅ Case records✅ SimpleShortLow⭐⭐⭐
38Digital health for antenatal medication adherenceProspective interventional⚠️ Smartphone access required⚠️ ModerateLongMedium⭐⭐
39IV vs. oral iron therapy in pregnancy anemiaProspective comparative✅ ANC ward/OPD⚠️ Moderate (IV access)MediumMedium⭐⭐⭐

Summary by Feasibility

⭐⭐⭐ High Feasibility (27 topics)

Topics: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 15, 16, 18, 22, 23, 24, 25, 27, 28, 29, 30, 32, 34, 35, 36, 37, 39

⭐⭐ Moderate Feasibility (10 topics)

Topics: 12, 17, 19, 20, 21, 26, 31, 33, 38

⭐ Low Feasibility

None - all topics are achievable within an M. Pharm timeframe with proper planning.

Best picks for a 1-year M. Pharm project (high feasibility + high publishability):
  • #9 - Pharmacist counseling on antenatal supplement adherence
  • #22 - KAP on OCP use
  • #14 - Drug-related problems in high-risk pregnancy
  • #39 - IV vs. oral iron in pregnancy anemia
  • #10 - ADR monitoring in obstetric drugs
Would you like a detailed study protocol (objectives, methodology, tools, sample size) for any of these?

nervous system related?

Here are M. Pharm (Pharmacy Practice) project topics for Neurology & Psychiatry (Nervous System), along with a feasibility comparison table:

Topic List

Drug Utilization & Prescribing Pattern Studies

  1. Drug utilization study of antiepileptic drugs (AEDs) in epilepsy patients
  2. Prescribing pattern of antidepressants in depressive disorders
  3. Drug utilization study of antipsychotics in schizophrenia inpatients
  4. Assessment of prescribing patterns in Parkinson's disease management
  5. Drug utilization review of anticoagulants/antiplatelets in ischemic stroke patients
  6. Prescribing pattern of drugs in migraine management - acute vs. prophylactic

Medication Adherence

  1. Assessment of medication adherence in epilepsy patients using MMAS-8
  2. Adherence to antipsychotic therapy in schizophrenia and associated factors
  3. Medication adherence in Parkinson's disease patients - barriers and determinants
  4. Impact of pharmacist counseling on adherence in depression patients
  5. Adherence to mood stabilizers in bipolar disorder patients

Adverse Drug Reactions & Pharmacovigilance

  1. ADR monitoring and reporting of antiepileptic drugs - incidence and patterns
  2. ADR profiling of atypical vs. typical antipsychotics in psychiatric inpatients
  3. Drug-induced movement disorders (EPS, tardive dyskinesia) surveillance in psychiatric patients
  4. ADR monitoring of antidepressants (SSRIs, SNRIs, TCAs) - causality and severity assessment
  5. Valproate-induced adverse effects monitoring - hepatotoxicity, weight gain, tremor

Drug-Related Problems (DRPs)

  1. Identification of drug-related problems in neurology ward patients using PCNE classification
  2. Drug-drug interactions in polypharmacy neurology/psychiatry patients
  3. Assessment of inappropriate prescribing in elderly neurological patients using Beers/STOPP-START criteria
  4. Medication errors in psychiatry ward - incidence, type, and pharmacist interventions

Clinical Pharmacist Interventions

  1. Impact of pharmacist-led medication review on DRPs in stroke patients
  2. Role of pharmacist in therapeutic drug monitoring (TDM) of antiepileptics (phenytoin, valproate, carbamazepine)
  3. Pharmacist intervention in reducing antipsychotic polypharmacy in schizophrenia
  4. Effect of pharmacist counseling on caregiver knowledge of neurological medications
  5. Pharmacist's role in clozapine monitoring - safety and outcome assessment

Patient Knowledge, Attitude & Practice (KAP)

  1. KAP of epilepsy patients toward their disease and medication
  2. Assessment of patient/caregiver knowledge on antidepressant therapy - myths and misconceptions
  3. Knowledge and awareness of stroke warning signs and medication use in at-risk patients
  4. KAP of psychiatric patients on antipsychotic medications and side effects

Pharmacoeconomics & Quality of Life

  1. Cost-of-illness study of epilepsy in a tertiary care neurology unit
  2. Health-related quality of life (HRQoL) in epilepsy patients using QOLIE-31 scale
  3. HRQoL assessment in schizophrenia patients using SF-36 / PANSS
  4. Pharmacoeconomic analysis of generic vs. branded antiepileptic drugs
  5. Direct and indirect costs in stroke patients - a burden-of-illness study

Specific Condition-Based Studies

  1. Evaluation of thromboprophylaxis practices in stroke patients
  2. Assessment of sleep disorder pharmacotherapy - benzodiazepine and Z-drug prescribing patterns
  3. Drug therapy evaluation in Alzheimer's disease - cholinesterase inhibitor use patterns
  4. Assessment of antiepileptic drug switching - reasons, outcomes, and pharmacist role
  5. Evaluation of ADHD pharmacotherapy in children/adolescents - safety and monitoring

Feasibility Comparison Table

#TopicStudy TypeData AccessEthics ComplexityTime RequiredCostOverall Feasibility
1Drug utilization of AEDs in epilepsyRetrospective/Prospective✅ OPD/ward records✅ SimpleShortLow⭐⭐⭐
2Prescribing pattern of antidepressantsRetrospective✅ OPD records✅ SimpleShortLow⭐⭐⭐
3Drug utilization of antipsychotics in schizophreniaRetrospective✅ Ward records✅ SimpleShortLow⭐⭐⭐
4Prescribing patterns in Parkinson's diseaseRetrospective✅ OPD records✅ SimpleShortLow⭐⭐⭐
5Anticoagulant/antiplatelet use in ischemic strokeRetrospective✅ Ward/case sheets✅ SimpleShortLow⭐⭐⭐
6Prescribing in migraine - acute vs. prophylacticCross-sectional✅ OPD records✅ SimpleShortLow⭐⭐⭐
7Adherence in epilepsy (MMAS-8)Cross-sectional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
8Adherence to antipsychotics in schizophreniaCross-sectional✅ OPD/ward patients✅ SimpleShortLow⭐⭐⭐
9Adherence in Parkinson's diseaseCross-sectional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
10Pharmacist counseling impact on adherence in depressionProspective interventional✅ OPD patients⚠️ Moderate (consent)MediumLow⭐⭐⭐
11Adherence to mood stabilizers in bipolar disorderCross-sectional✅ OPD/ward patients✅ SimpleShortLow⭐⭐⭐
12ADR monitoring of AEDsProspective observational✅ Ward/OPD patients✅ SimpleMediumLow⭐⭐⭐
13ADR profiling - atypical vs. typical antipsychoticsProspective comparative✅ Psychiatric ward✅ SimpleMediumLow⭐⭐⭐
14Drug-induced movement disorders surveillanceProspective observational✅ Psychiatric ward✅ SimpleMediumLow⭐⭐⭐
15ADR monitoring of antidepressantsProspective observational✅ OPD/ward patients✅ SimpleMediumLow⭐⭐⭐
16Valproate-induced ADR monitoringProspective observational✅ Neurology/psychiatry ward✅ SimpleMediumLow⭐⭐⭐
17DRPs in neurology ward (PCNE)Prospective observational✅ Ward patients⚠️ Moderate (consent)MediumLow⭐⭐⭐
18Drug-drug interactions in neuro/psych polypharmacyRetrospective/Prospective✅ Prescriptions✅ SimpleShortLow⭐⭐⭐
19Inappropriate prescribing in elderly (Beers/STOPP-START)Retrospective✅ Case records✅ SimpleShortLow⭐⭐⭐
20Medication errors in psychiatry wardProspective observational⚠️ Staff cooperation needed⚠️ ModerateMediumLow⭐⭐
21Pharmacist medication review in stroke patientsProspective interventional✅ Stroke ward⚠️ ModerateMediumLow⭐⭐⭐
22Pharmacist role in TDM of AEDsProspective observational✅ Neurology ward/TDM lab✅ SimpleMediumLow⭐⭐⭐
23Pharmacist intervention in antipsychotic polypharmacyProspective interventional⚠️ Needs physician cooperation⚠️ ModerateMediumLow⭐⭐
24Pharmacist counseling on caregiver knowledgeProspective interventional✅ OPD caregivers✅ SimpleMediumLow⭐⭐⭐
25Clozapine monitoring - safety and outcomesProspective observational⚠️ Clozapine registry access⚠️ ModerateLongLow⭐⭐
26KAP of epilepsy patients on disease/medicationCross-sectional survey✅ OPD patients✅ SimpleShortLow⭐⭐⭐
27Patient/caregiver knowledge on antidepressantsCross-sectional survey✅ OPD patients✅ SimpleShortLow⭐⭐⭐
28Stroke warning signs awareness in at-risk patientsCross-sectional survey✅ OPD/ward patients✅ SimpleShortLow⭐⭐⭐
29KAP of psychiatric patients on antipsychoticsCross-sectional survey✅ Psychiatric OPD✅ SimpleShortLow⭐⭐⭐
30Cost-of-illness study of epilepsyRetrospective/Prospective✅ Hospital billing + records⚠️ ModerateMediumLow⭐⭐
31HRQoL in epilepsy using QOLIE-31Cross-sectional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
32HRQoL in schizophrenia using SF-36/PANSSCross-sectional✅ OPD/ward patients✅ SimpleShortLow⭐⭐⭐
33Generic vs. branded AED pharmacoeconomicsRetrospective comparative✅ Hospital/pharmacy records✅ SimpleShortLow⭐⭐⭐
34Cost burden in stroke patientsRetrospective✅ Hospital billing⚠️ ModerateMediumLow⭐⭐
35Thromboprophylaxis practices in strokeRetrospective✅ Case sheets✅ SimpleShortLow⭐⭐⭐
36Sleep disorder pharmacotherapy - BZD/Z-drug patternsRetrospective✅ OPD records✅ SimpleShortLow⭐⭐⭐
37Alzheimer's disease - cholinesterase inhibitor patternsRetrospective⚠️ Fewer patients available✅ SimpleMediumLow⭐⭐
38AED switching - reasons, outcomes, pharmacist roleProspective observational✅ Neurology OPD✅ SimpleMediumLow⭐⭐⭐
39ADHD pharmacotherapy in children - safety monitoringProspective observational⚠️ Pediatric ethics needed⚠️ ComplexLongMedium

Summary by Feasibility

RatingCountTopic Numbers
⭐⭐⭐ High301-19 (except 20), 21-22, 24, 26-29, 31-33, 35-36, 38
⭐⭐ Moderate820, 23, 25, 30, 34, 37
⭐ Difficult139

Top 5 Picks (High Feasibility + Publishability)

#TopicStrength
7Medication adherence in epilepsy (MMAS-8)Simple, validated tool, large patient pool
17DRPs in neurology ward (PCNE)High clinical impact, structured methodology
22Pharmacist role in TDM of AEDsUnique clinical pharmacist role, lab-based
31HRQoL in epilepsy (QOLIE-31)Patient-centered, validated scale, publishable
12ADR monitoring of AEDsPharmacovigilance focus, simple prospective design

Would you like a detailed study protocol for any of these, or shall I compile all topics from Cardiology, Gynecology, and Neurology into one master Excel file for download?

elder patient related

Here are M. Pharm (Pharmacy Practice) project topics focused on Elderly Patients (Geriatric Pharmacy), with a feasibility comparison table:

Topic List

Polypharmacy & Inappropriate Prescribing

  1. Prevalence of polypharmacy in elderly inpatients and associated risk factors
  2. Assessment of inappropriate prescribing in elderly using Beers Criteria 2023
  3. Assessment of inappropriate prescribing using STOPP/START criteria v3
  4. Comparison of Beers vs. STOPP/START criteria in detecting inappropriate prescribing in elderly
  5. Prevalence of potentially inappropriate medications (PIMs) in elderly outpatients
  6. Drug burden index (DBI) assessment in community-dwelling elderly patients

Medication Adherence

  1. Assessment of medication adherence in elderly patients with multiple chronic conditions (MMAS-8)
  2. Factors affecting medication non-adherence in geriatric outpatients
  3. Impact of pill organizer/blister pack on medication adherence in elderly
  4. Role of caregiver support on medication adherence in elderly patients
  5. Impact of pharmacist-led medication counseling on adherence in elderly - interventional study

Adverse Drug Reactions & Drug Safety

  1. Incidence and pattern of ADRs in hospitalized elderly patients
  2. ADR-related hospital admissions in elderly - a prospective study
  3. Drug-induced falls in elderly patients - assessment and pharmacist intervention
  4. ADR monitoring of high-alert medications (anticoagulants, digoxin, insulin) in elderly
  5. Drug-induced cognitive impairment in elderly - assessment of anticholinergic drug burden

Drug-Related Problems (DRPs)

  1. Identification of drug-related problems in elderly inpatients using PCNE classification
  2. Drug-drug interactions in elderly polypharmacy patients - prevalence and clinical significance
  3. Medication-related problems during care transitions (hospital to home) in elderly
  4. Assessment of renal function-based dose adjustments in elderly hospitalized patients

Deprescribing

  1. Assessment of deprescribing practices in elderly patients on polypharmacy
  2. Pharmacist-led deprescribing intervention in elderly patients - outcomes and physician acceptance
  3. Evaluation of proton pump inhibitor (PPI) overuse and deprescribing in elderly
  4. Benzodiazepine/Z-drug deprescribing in elderly - patterns and pharmacist role
  5. Assessment of statin deprescribing in elderly patients with limited life expectancy

Clinical Pharmacist Interventions

  1. Impact of clinical pharmacist medication review on drug-related problems in geriatric ward
  2. Pharmacist-led comprehensive medication review (CMR) in elderly outpatients
  3. Role of pharmacist in fall prevention programs in elderly hospitalized patients
  4. Pharmacist's contribution during geriatric ward rounds - types and acceptance of recommendations
  5. Pharmacist-led anticoagulation management in elderly atrial fibrillation patients

Patient Knowledge & Health Literacy

  1. Assessment of health literacy and its impact on medication adherence in elderly
  2. KAP of elderly patients on their chronic disease medications
  3. Assessment of elderly patients' ability to understand prescription labels and instructions
  4. Self-medication practices and associated risks in elderly patients

Quality of Life & Pharmacoeconomics

  1. Health-related quality of life (HRQoL) in elderly patients with multimorbidity using EQ-5D
  2. Cost-of-illness study of polypharmacy-related adverse outcomes in elderly
  3. Pharmacoeconomic impact of pharmacist interventions in geriatric patients
  4. HRQoL assessment in elderly patients with chronic pain using SF-36

Specific Condition-Based / Emerging Topics

  1. Anticholinergic drug burden assessment using ACB scale in elderly patients
  2. Assessment of fall risk and medications contributing to falls (fall-risk-increasing drugs - FRIDs)
  3. Evaluation of nutritional supplement and drug interactions in elderly
  4. Medication management in elderly patients with dementia - caregiver perspectives
  5. Pharmacist role in managing pain in elderly cancer patients - opioid safety monitoring
  6. Vaccination coverage and pharmacist counseling role in elderly patients
  7. Assessment of smart medication dispensing/reminder technology uptake in elderly

Feasibility Comparison Table

#TopicStudy TypeData AccessEthics ComplexityTime RequiredCostOverall Feasibility
1Prevalence of polypharmacy in elderly inpatientsCross-sectional✅ Ward records✅ SimpleShortLow⭐⭐⭐
2Inappropriate prescribing - Beers Criteria 2023Retrospective/Cross-sectional✅ OPD/ward records✅ SimpleShortLow⭐⭐⭐
3Inappropriate prescribing - STOPP/START v3Retrospective/Cross-sectional✅ OPD/ward records✅ SimpleShortLow⭐⭐⭐
4Beers vs. STOPP/START comparisonRetrospective comparative✅ Case records✅ SimpleShortLow⭐⭐⭐
5PIMs in elderly outpatientsCross-sectional✅ OPD prescriptions✅ SimpleShortLow⭐⭐⭐
6Drug burden index in community elderlyCross-sectional⚠️ Community recruitment⚠️ ModerateMediumLow⭐⭐
7Medication adherence - MMAS-8 in elderlyCross-sectional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
8Factors affecting non-adherence in elderlyCross-sectional survey✅ OPD patients✅ SimpleShortLow⭐⭐⭐
9Pill organizer impact on adherenceProspective interventional✅ OPD patients⚠️ Moderate (consent)MediumLow⭐⭐⭐
10Caregiver support and adherenceCross-sectional✅ OPD patients + caregivers✅ SimpleShortLow⭐⭐⭐
11Pharmacist counseling impact on adherenceProspective interventional✅ OPD patients⚠️ Moderate (consent)MediumLow⭐⭐⭐
12Incidence and pattern of ADRs in elderly inpatientsProspective observational✅ Ward patients✅ SimpleMediumLow⭐⭐⭐
13ADR-related hospital admissions in elderlyProspective observational✅ Admission records✅ SimpleMediumLow⭐⭐⭐
14Drug-induced falls in elderlyProspective observational✅ Ward + fall incident reports⚠️ ModerateMediumLow⭐⭐⭐
15ADR monitoring of high-alert drugs in elderlyProspective observational✅ Ward patients✅ SimpleMediumLow⭐⭐⭐
16Anticholinergic drug burden and cognitive impairmentCross-sectional✅ OPD/ward elderly⚠️ ModerateMediumLow⭐⭐⭐
17DRPs in elderly inpatients (PCNE)Prospective observational✅ Ward patients⚠️ Moderate (consent)MediumLow⭐⭐⭐
18Drug-drug interactions in elderly polypharmacyRetrospective/Prospective✅ Prescriptions✅ SimpleShortLow⭐⭐⭐
19Medication problems during care transitionsProspective observational⚠️ Discharge follow-up needed⚠️ ModerateLongLow⭐⭐
20Renal function-based dose adjustment assessmentRetrospective✅ Lab + case records✅ SimpleShortLow⭐⭐⭐
21Deprescribing practices in elderly polypharmacyCross-sectional/Retrospective✅ Case records✅ SimpleShortLow⭐⭐⭐
22Pharmacist-led deprescribing interventionProspective interventional⚠️ Physician cooperation needed⚠️ ModerateMediumLow⭐⭐
23PPI overuse and deprescribing in elderlyRetrospective✅ OPD/ward records✅ SimpleShortLow⭐⭐⭐
24BZD/Z-drug deprescribing patternsRetrospective✅ Pharmacy/OPD records✅ SimpleShortLow⭐⭐⭐
25Statin deprescribing in elderlyRetrospective/Cross-sectional✅ OPD records✅ SimpleShortLow⭐⭐⭐
26Pharmacist medication review in geriatric wardProspective interventional✅ Ward patients⚠️ ModerateMediumLow⭐⭐⭐
27Comprehensive medication review (CMR) in elderly OPDProspective interventional✅ OPD patients⚠️ ModerateMediumLow⭐⭐⭐
28Pharmacist role in fall preventionProspective interventional✅ Ward patients⚠️ ModerateMediumLow⭐⭐
29Pharmacist recommendations in geriatric ward roundsProspective observational⚠️ Physician cooperation⚠️ ModerateMediumLow⭐⭐
30Pharmacist anticoagulation management in elderly AFProspective observational✅ Cardiology/medicine OPD✅ SimpleMediumLow⭐⭐⭐
31Health literacy and medication adherence in elderlyCross-sectional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
32KAP on chronic disease medications in elderlyCross-sectional survey✅ OPD patients✅ SimpleShortLow⭐⭐⭐
33Ability to understand prescription labels in elderlyCross-sectional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
34Self-medication practices in elderlyCross-sectional survey✅ OPD/community✅ SimpleShortLow⭐⭐⭐
35HRQoL in elderly with multimorbidity (EQ-5D)Cross-sectional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
36Cost-of-illness of polypharmacy adverse outcomesRetrospective✅ Hospital billing + records⚠️ ModerateMediumLow⭐⭐
37Pharmacoeconomic impact of pharmacist interventionsProspective⚠️ Billing data access needed⚠️ ModerateLongLow⭐⭐
38HRQoL in elderly chronic pain (SF-36)Cross-sectional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
39Anticholinergic burden (ACB scale) in elderlyCross-sectional✅ OPD/ward records✅ SimpleShortLow⭐⭐⭐
40Fall-risk-increasing drugs (FRIDs) assessmentRetrospective/Prospective✅ Ward + fall records✅ SimpleMediumLow⭐⭐⭐
41Nutritional supplement - drug interactions in elderlyCross-sectional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
42Medication management in elderly with dementiaCross-sectional (caregivers)✅ Neurology/psychiatry OPD✅ SimpleShortLow⭐⭐⭐
43Pain management and opioid safety in elderly cancerProspective observational⚠️ Palliative/oncology unit access⚠️ ModerateMediumLow⭐⭐
44Vaccination coverage and pharmacist counseling in elderlyCross-sectional + interventional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
45Smart medication technology uptake in elderlyCross-sectional survey✅ OPD patients✅ SimpleShortLow⭐⭐⭐

Summary by Feasibility

RatingCountTopic Numbers
⭐⭐⭐ High351-5, 7-18, 20-21, 23-27, 30-35, 38-42, 44-45
⭐⭐ Moderate96, 19, 22, 28, 29, 36, 37, 43
⭐ Difficult0-

Top 5 Picks for M. Pharm (Geriatric Focus)

#TopicWhy it Stands Out
2Inappropriate prescribing using Beers Criteria 2023Updated criteria, widely cited, simple retrospective design
4Beers vs. STOPP/START comparisonNovel comparative angle, high publishability
39Anticholinergic burden (ACB scale)Emerging topic, validated tool, very feasible
40FRIDs assessment and fallsClinically impactful, safety-focused, easy data access
17DRPs in elderly inpatients (PCNE)Gold-standard classification, strong clinical relevance

Would you like me to now compile all topics from Cardiology, Gynecology, Neurology, and Geriatrics into one master Excel file with feasibility ratings for easy comparison and download?

oncology?

Here are M. Pharm (Pharmacy Practice) project topics for Oncology, with a full feasibility comparison table:

Topic List

Drug Utilization & Prescribing Pattern Studies

  1. Drug utilization study of chemotherapy regimens in breast cancer patients
  2. Prescribing pattern analysis in colorectal cancer - adherence to NCCN/ESMO guidelines
  3. Drug utilization review of targeted therapy in non-small cell lung cancer (NSCLC)
  4. Assessment of supportive care medication use (antiemetics, G-CSF, analgesics) in chemotherapy patients
  5. Prescribing pattern of opioid analgesics in cancer pain management
  6. Evaluation of chemotherapy regimens in hematological malignancies (leukemia/lymphoma)

Adverse Drug Reactions & Pharmacovigilance

  1. ADR monitoring and reporting in cancer patients receiving chemotherapy - incidence and patterns
  2. Chemotherapy-induced nausea and vomiting (CINV) - assessment and management evaluation
  3. Chemotherapy-induced peripheral neuropathy (CIPN) surveillance and grading (CTCAE)
  4. Hematological toxicity monitoring in cancer patients on cytotoxic therapy
  5. ADR profiling of targeted therapy/immunotherapy (checkpoint inhibitors) - immune-related adverse events (irAEs)
  6. Cardiotoxicity monitoring in patients on anthracycline-based chemotherapy
  7. Drug-induced nephrotoxicity and hepatotoxicity surveillance in oncology patients
  8. ADR causality and severity assessment using Naranjo scale and CTCAE in oncology ward

Medication Errors & Safety

  1. Incidence and types of chemotherapy medication errors in oncology ward/day care
  2. Assessment of chemotherapy preparation and dispensing errors in hospital pharmacy
  3. High-alert medication safety practices for chemotherapy agents - gap analysis
  4. Evaluation of chemotherapy dose calculation errors - actual vs. prescribed BSA-based dosing

Drug-Related Problems (DRPs)

  1. Identification of drug-related problems in oncology inpatients using PCNE classification
  2. Drug-drug interactions in cancer patients on polypharmacy - prevalence and clinical significance
  3. Assessment of drug-nutrient interactions in cancer patients on chemotherapy
  4. Evaluation of supportive care prescribing gaps in chemotherapy patients

Clinical Pharmacist Interventions

  1. Impact of clinical pharmacist interventions on drug-related problems in oncology ward
  2. Role of pharmacist in chemotherapy review and dose verification - error prevention
  3. Pharmacist-led antiemetic protocol optimization in CINV management
  4. Role of pharmacist in pain management in palliative cancer patients
  5. Pharmacist interventions in improving supportive care medication use
  6. Assessment of pharmacist recommendations during oncology multidisciplinary team (MDT) meetings

Medication Adherence

  1. Adherence to oral chemotherapy agents (capecitabine, imatinib, erlotinib) and associated factors
  2. Impact of pharmacist counseling on adherence to oral targeted therapy
  3. Factors affecting adherence to hormonal therapy in breast cancer (tamoxifen, letrozole)
  4. Adherence to supportive medications (antiemetics, steroids) during chemotherapy cycles

Patient Knowledge, Attitude & Practice (KAP)

  1. KAP of cancer patients on chemotherapy side effects and self-management
  2. Assessment of patient knowledge on oral chemotherapy - safe handling and storage
  3. Patient awareness of palliative care and pharmacist's role in symptom management
  4. KAP of oncology nurses and pharmacists on chemotherapy safe handling practices

Pharmacoeconomics & Quality of Life

  1. Cost-of-illness study of breast/lung/colorectal cancer in a tertiary care hospital
  2. Pharmacoeconomic analysis of generic vs. innovator chemotherapy agents
  3. Health-related quality of life (HRQoL) in cancer patients using EORTC QLQ-C30
  4. Economic burden of chemotherapy-induced toxicities - direct medical cost analysis
  5. Cost-effectiveness of antiemetic regimens in CINV prevention

Specific / Emerging Topics

  1. Assessment of biosimilar use in oncology - prescribing patterns and pharmacist awareness
  2. Evaluation of palliative care pharmacotherapy - symptom control audit
  3. Pharmacist's role in immunotherapy (checkpoint inhibitor) toxicity monitoring
  4. Assessment of cancer pain undertreatment - WHO analgesic ladder adherence
  5. Medication reconciliation in cancer patients at hospital admission and discharge
  6. Evaluation of antibiotic use in febrile neutropenia - appropriateness and outcomes
  7. Pharmacist's role in chemotherapy-induced oral mucositis prevention and management

Feasibility Comparison Table

#TopicStudy TypeData AccessEthics ComplexityTime RequiredCostOverall Feasibility
1Drug utilization in breast cancer chemoRetrospective✅ Ward/case records✅ SimpleShortLow⭐⭐⭐
2Prescribing pattern in colorectal cancerRetrospective✅ Ward records✅ SimpleShortLow⭐⭐⭐
3Drug utilization of targeted therapy in NSCLCRetrospective✅ Ward/OPD records✅ SimpleShortLow⭐⭐⭐
4Supportive care medication use in chemo patientsProspective/Retrospective✅ Ward records✅ SimpleShortLow⭐⭐⭐
5Opioid prescribing in cancer painRetrospective✅ Prescription records✅ SimpleShortLow⭐⭐⭐
6Chemo regimens in hematological malignanciesRetrospective✅ Ward/case records✅ SimpleShortLow⭐⭐⭐
7ADR monitoring in chemo patientsProspective observational✅ Ward patients✅ SimpleMediumLow⭐⭐⭐
8CINV assessment and managementProspective observational✅ Day care/ward patients✅ SimpleMediumLow⭐⭐⭐
9CIPN surveillance (CTCAE grading)Prospective observational✅ OPD/ward patients✅ SimpleMediumLow⭐⭐⭐
10Hematological toxicity monitoringProspective observational✅ Ward + lab records✅ SimpleMediumLow⭐⭐⭐
11irAEs with immunotherapy/checkpoint inhibitorsProspective observational⚠️ Limited immunotherapy patients⚠️ ModerateLongLow⭐⭐
12Cardiotoxicity in anthracycline-based chemoProspective observational✅ Ward + ECHO records⚠️ ModerateMediumLow⭐⭐⭐
13Drug-induced nephrotoxicity/hepatotoxicityProspective observational✅ Ward + lab records✅ SimpleMediumLow⭐⭐⭐
14ADR causality/severity (Naranjo + CTCAE)Prospective observational✅ Ward patients✅ SimpleMediumLow⭐⭐⭐
15Chemo medication errors in oncology wardProspective observational⚠️ Staff cooperation needed⚠️ ModerateMediumLow⭐⭐
16Chemo preparation/dispensing errorsProspective observational⚠️ Pharmacy unit access⚠️ ModerateMediumLow⭐⭐
17High-alert chemo medication safety gap analysisCross-sectional/Audit✅ Pharmacy/ward records✅ SimpleShortLow⭐⭐⭐
18Chemo dose calculation errors (BSA-based)Retrospective✅ Prescription records✅ SimpleShortLow⭐⭐⭐
19DRPs in oncology inpatients (PCNE)Prospective observational✅ Ward patients⚠️ Moderate (consent)MediumLow⭐⭐⭐
20Drug-drug interactions in cancer polypharmacyRetrospective/Prospective✅ Prescriptions✅ SimpleShortLow⭐⭐⭐
21Drug-nutrient interactions in chemo patientsCross-sectional✅ OPD/ward patients✅ SimpleShortLow⭐⭐⭐
22Supportive care prescribing gapsRetrospective/Audit✅ Case records✅ SimpleShortLow⭐⭐⭐
23Pharmacist interventions on DRPs in oncologyProspective interventional✅ Ward patients⚠️ ModerateMediumLow⭐⭐⭐
24Pharmacist role in chemo review/dose verificationProspective observational✅ Pharmacy/ward✅ SimpleMediumLow⭐⭐⭐
25Pharmacist-led antiemetic protocol optimizationProspective interventional✅ Day care/ward⚠️ ModerateMediumLow⭐⭐⭐
26Pharmacist in pain management - palliativeProspective observational✅ Palliative care unit⚠️ ModerateMediumLow⭐⭐
27Pharmacist interventions in supportive careProspective interventional✅ Ward patients⚠️ ModerateMediumLow⭐⭐⭐
28Pharmacist recommendations in oncology MDTProspective observational⚠️ MDT access needed⚠️ ModerateLongLow⭐⭐
29Adherence to oral chemotherapy agentsCross-sectional/Prospective✅ OPD patients✅ SimpleMediumLow⭐⭐⭐
30Pharmacist counseling impact on oral targeted therapy adherenceProspective interventional✅ OPD patients⚠️ Moderate (consent)MediumLow⭐⭐⭐
31Adherence to hormonal therapy in breast cancerCross-sectional✅ OPD patients✅ SimpleShortLow⭐⭐⭐
32Adherence to supportive medications during chemoProspective observational✅ Day care patients✅ SimpleMediumLow⭐⭐⭐
33KAP on chemo side effects and self-managementCross-sectional survey✅ OPD/ward patients✅ SimpleShortLow⭐⭐⭐
34Patient knowledge on oral chemo handling/storageCross-sectional survey✅ OPD patients✅ SimpleShortLow⭐⭐⭐
35Patient awareness of palliative careCross-sectional survey✅ Ward/OPD patients✅ SimpleShortLow⭐⭐⭐
36KAP of oncology staff on chemo safe handlingCross-sectional survey✅ Nurses/pharmacists✅ SimpleShortLow⭐⭐⭐
37Cost-of-illness in breast/lung/colorectal cancerRetrospective✅ Hospital billing⚠️ ModerateMediumLow⭐⭐
38Generic vs. innovator chemo pharmacoeconomicsRetrospective comparative✅ Pharmacy/billing records✅ SimpleShortLow⭐⭐⭐
39HRQoL in cancer patients (EORTC QLQ-C30)Cross-sectional✅ OPD/ward patients✅ SimpleShortLow⭐⭐⭐
40Economic burden of chemo-induced toxicitiesRetrospective✅ Hospital billing⚠️ ModerateMediumLow⭐⭐
41Cost-effectiveness of antiemetic regimensRetrospective comparative✅ Pharmacy + billing records✅ SimpleShortLow⭐⭐⭐
42Biosimilar use in oncology - patterns and awarenessCross-sectional✅ Pharmacy/ward records✅ SimpleShortLow⭐⭐⭐
43Palliative care pharmacotherapy auditRetrospective/Audit✅ Palliative ward records✅ SimpleShortLow⭐⭐⭐
44Immunotherapy toxicity monitoring (pharmacist role)Prospective observational⚠️ Limited patient numbers⚠️ ModerateLongLow⭐⭐
45Cancer pain undertreatment - WHO ladder adherenceCross-sectional/Retrospective✅ OPD/ward records✅ SimpleShortLow⭐⭐⭐
46Medication reconciliation in cancer patientsProspective observational✅ Admission/discharge records⚠️ ModerateMediumLow⭐⭐⭐
47Antibiotic use in febrile neutropeniaRetrospective/Prospective✅ Ward records + culture reports✅ SimpleMediumLow⭐⭐⭐
48Chemo-induced oral mucositis - prevention/managementProspective observational✅ Day care/ward patients✅ SimpleMediumLow⭐⭐⭐

Summary by Feasibility

RatingCountTopic Numbers
⭐⭐⭐ High381-10, 12-14, 17-25, 27, 29-36, 38-39, 41-43, 45-48
⭐⭐ Moderate1011, 15, 16, 26, 28, 37, 40, 44
⭐ Difficult0-

Top 5 Picks for M. Pharm (Oncology)

#TopicWhy it Stands Out
8CINV assessment and management evaluationVery common, clear outcomes, day care patients easy to recruit
39HRQoL using EORTC QLQ-C30Gold-standard validated tool, patient-centered, highly publishable
19DRPs in oncology inpatients (PCNE)Structured tool, high clinical impact, strong for publication
45Cancer pain undertreatment - WHO ladderClinically critical, simple retrospective + prospective design
29Adherence to oral chemotherapy agentsGrowing oral chemo use makes this very timely and relevant

Shall I now compile all topics across Cardiology, Gynecology, Neurology, Geriatrics, and Oncology into one master Excel file with feasibility ratings for easy download and reference?

pharmacogenomics?

Here are M. Pharm (Pharmacy Practice) project topics for Pharmacogenomics, with a full feasibility comparison table:

Topic List

Awareness, Knowledge & Attitude Studies

  1. Assessment of knowledge, attitude and practice (KAP) of pharmacists on pharmacogenomics
  2. Awareness of pharmacogenomics among physicians in a tertiary care hospital
  3. KAP of clinical pharmacists on implementing pharmacogenomics in patient care
  4. Assessment of pharmacogenomics education in pharmacy curriculum - student perspectives
  5. Awareness of pharmacogenomics testing among patients with chronic diseases

Drug Metabolism & CYP450 Polymorphism Studies

  1. Assessment of CYP2C19 polymorphism and clopidogrel response in cardiac patients
  2. CYP2D6 polymorphism and its influence on antidepressant (fluoxetine/codeine) therapy outcomes
  3. CYP2C9 and VKORC1 polymorphism impact on warfarin dosing requirements
  4. CYP3A4/3A5 polymorphism and tacrolimus dose variability in transplant patients
  5. CYP2C19 genotype and proton pump inhibitor (PPI) efficacy in H. pylori eradication

Oncology Pharmacogenomics

  1. DPYD gene polymorphism and fluorouracil (5-FU) toxicity in cancer patients
  2. TPMT/NUDT15 genotype and thiopurine (azathioprine/6-MP) toxicity in leukemia/IBD patients
  3. HER2/EGFR mutation status and targeted therapy response in breast/lung cancer
  4. UGT1A1 polymorphism and irinotecan-induced toxicity (neutropenia/diarrhea)
  5. BRCA1/2 mutation assessment and its implication on treatment decisions in breast/ovarian cancer
  6. Pharmacogenomics of tamoxifen metabolism (CYP2D6) and outcomes in breast cancer

Cardiology Pharmacogenomics

  1. Pharmacogenomics of antiplatelet therapy - CYP2C19 genotyping in ACS/PCI patients
  2. Genetic determinants of statin-induced myopathy - SLCO1B1 polymorphism assessment
  3. Pharmacogenomics of antihypertensive drug response - ACE inhibitor/beta-blocker outcomes
  4. Warfarin pharmacogenomics (CYP2C9 + VKORC1) - genotype-guided dosing vs. standard dosing

Psychiatry & Neurology Pharmacogenomics

  1. CYP2D6/CYP2C19 polymorphism and antidepressant response/ADRs in depressive disorder patients
  2. Pharmacogenomics of antipsychotic therapy - metabolizer status and drug response in schizophrenia
  3. HLA-B*15:02 allele screening and carbamazepine-induced Stevens-Johnson syndrome risk
  4. HLA-B*57:01 screening and abacavir hypersensitivity in HIV patients
  5. Pharmacogenomics of pain management - OPRM1 polymorphism and opioid response

Implementation & Clinical Decision Support

  1. Evaluation of pharmacogenomics-guided prescribing vs. standard prescribing - clinical outcomes
  2. Pharmacist-led pharmacogenomics counseling service - feasibility and patient acceptance
  3. Barriers to clinical implementation of pharmacogenomics in Indian/developing country hospitals
  4. Assessment of pharmacogenomics clinical decision support tools (CPIC guidelines) awareness among clinicians
  5. Pilot implementation of pre-emptive pharmacogenomics testing in a hospital setting

Specific Population Studies

  1. Pharmacogenomics of antitubercular drugs - NAT2 polymorphism and isoniazid-induced hepatotoxicity
  2. G6PD deficiency screening before primaquine/dapsone therapy in malaria patients
  3. HLA-B*58:01 and allopurinol-induced severe cutaneous adverse reactions (SCARs) in gout patients
  4. Pharmacogenomics in pediatric oncology - TPMT genotyping before thiopurine therapy
  5. Ethnic differences in drug metabolism enzymes - a cross-sectional pharmacogenomics study

Emerging Topics

  1. Role of pharmacist in pre-emptive pharmacogenomics testing programs
  2. Patient perspectives on pharmacogenomics testing - willingness, privacy concerns, and barriers
  3. Pharmacogenomics of COVID-19 drug therapy - ACE2 polymorphism and drug response
  4. Artificial intelligence and pharmacogenomics - awareness and future applications in pharmacy practice
  5. Assessment of direct-to-consumer (DTC) pharmacogenomics testing - awareness among healthcare professionals

Feasibility Comparison Table

#TopicStudy TypeData AccessLab/Genotyping RequiredEthics ComplexityTime RequiredCostOverall Feasibility
1KAP of pharmacists on pharmacogenomicsCross-sectional survey✅ Pharmacists as subjects❌ No✅ SimpleShortLow⭐⭐⭐
2Awareness among physiciansCross-sectional survey✅ Physicians as subjects❌ No✅ SimpleShortLow⭐⭐⭐
3KAP of clinical pharmacists on PGx implementationCross-sectional survey✅ Pharmacists as subjects❌ No✅ SimpleShortLow⭐⭐⭐
4PGx education in pharmacy curriculumCross-sectional survey✅ Students as subjects❌ No✅ SimpleShortLow⭐⭐⭐
5Patient awareness of PGx testingCross-sectional survey✅ OPD patients❌ No✅ SimpleShortLow⭐⭐⭐
6CYP2C19 and clopidogrel responseProspective observational⚠️ Cardiology ward✅ Yes - genotyping⚠️ ModerateLongHigh
7CYP2D6 and antidepressant outcomesProspective observational⚠️ Psychiatry ward✅ Yes - genotyping⚠️ ModerateLongHigh
8CYP2C9/VKORC1 and warfarin dosingProspective observational✅ Anticoagulation clinic✅ Yes - genotyping⚠️ ModerateLongHigh⭐⭐
9CYP3A4/3A5 and tacrolimus variabilityProspective observational⚠️ Transplant unit access✅ Yes - genotyping⚠️ ModerateLongHigh
10CYP2C19 and PPI efficacy in H. pyloriProspective observational✅ Gastro OPD✅ Yes - genotyping⚠️ ModerateLongHigh⭐⭐
11DPYD and 5-FU toxicityProspective observational✅ Oncology ward✅ Yes - genotyping⚠️ ModerateLongHigh⭐⭐
12TPMT/NUDT15 and thiopurine toxicityProspective observational✅ Oncology/GI ward✅ Yes - genotyping⚠️ ModerateLongHigh⭐⭐
13HER2/EGFR mutation and targeted therapyRetrospective✅ Oncology records + lab⚠️ Usually done clinically✅ SimpleShortLow⭐⭐⭐
14UGT1A1 and irinotecan toxicityProspective observational✅ Oncology ward✅ Yes - genotyping⚠️ ModerateLongHigh⭐⭐
15BRCA1/2 mutation and treatment decisionsRetrospective✅ Oncology records⚠️ Existing reports used⚠️ ModerateMediumLow⭐⭐⭐
16CYP2D6 and tamoxifen outcomesProspective/Retrospective✅ Oncology OPD✅ Yes - genotyping⚠️ ModerateLongHigh⭐⭐
17CYP2C19 genotyping in ACS/PCIProspective observational✅ Cardiology ward✅ Yes - genotyping⚠️ ModerateLongHigh⭐⭐
18SLCO1B1 and statin-induced myopathyProspective/Retrospective✅ Cardiology OPD✅ Yes - genotyping⚠️ ModerateLongHigh⭐⭐
19PGx of antihypertensive responseProspective observational✅ Cardiology OPD✅ Yes - genotyping⚠️ ModerateLongHigh
20Warfarin PGx - genotype vs. standard dosingProspective comparative✅ Anticoagulation clinic✅ Yes - genotyping⚠️ ModerateLongHigh⭐⭐
21CYP2D6/CYP2C19 and antidepressant ADRsProspective observational✅ Psychiatry OPD✅ Yes - genotyping⚠️ ModerateLongHigh⭐⭐
22PGx of antipsychotic responseProspective observational✅ Psychiatry ward✅ Yes - genotyping⚠️ ModerateLongHigh
23HLA-B*15:02 and carbamazepine-SJS riskRetrospective/Cross-sectional✅ Neurology/dermatology records⚠️ Partial (existing test data)⚠️ ModerateMediumMedium⭐⭐⭐
24HLA-B*57:01 and abacavir hypersensitivityRetrospective✅ HIV clinic records⚠️ Existing test data✅ SimpleShortLow⭐⭐⭐
25OPRM1 and opioid responseProspective observational⚠️ Pain/palliative unit✅ Yes - genotyping⚠️ ModerateLongHigh
26PGx-guided vs. standard prescribingProspective comparative⚠️ Multiple unit access✅ Yes - genotyping⚠️ ComplexLongVery High
27Pharmacist-led PGx counseling serviceProspective interventional✅ OPD patients⚠️ ModerateMediumMedium⭐⭐
28Barriers to PGx implementation in hospitalsCross-sectional survey✅ HCPs as subjects❌ No✅ SimpleShortLow⭐⭐⭐
29CPIC guidelines awareness among cliniciansCross-sectional survey✅ Physicians/pharmacists❌ No✅ SimpleShortLow⭐⭐⭐
30Pilot pre-emptive PGx testing implementationInterventional⚠️ Institutional support needed✅ Yes - genotyping⚠️ ComplexLongVery High
31NAT2 and isoniazid hepatotoxicityProspective observational✅ TB ward/DOTS✅ Yes - genotyping⚠️ ModerateLongHigh⭐⭐
32G6PD screening before primaquine/dapsoneRetrospective/Cross-sectional✅ Medicine/tropical ward⚠️ Basic enzyme assay✅ SimpleShortLow⭐⭐⭐
33HLA-B*58:01 and allopurinol-SCARsRetrospective✅ Dermatology/rheumatology records⚠️ Existing test data✅ SimpleShortLow⭐⭐⭐
34TPMT genotyping in pediatric oncologyProspective observational⚠️ Pediatric oncology access✅ Yes - genotyping⚠️ ComplexLongHigh
35Ethnic differences in drug metabolismCross-sectional⚠️ Literature + existing genotype data✅ Partial⚠️ ModerateMediumMedium⭐⭐
36Pharmacist role in pre-emptive PGx testingCross-sectional/Qualitative✅ Pharmacists as subjects❌ No✅ SimpleShortLow⭐⭐⭐
37Patient perspectives on PGx testingCross-sectional survey✅ OPD patients✅ SimpleShortLow⭐⭐⭐
38PGx of COVID-19 drug therapyRetrospective/Review✅ Published data + records❌ No✅ SimpleShortLow⭐⭐⭐
39AI and pharmacogenomics - awareness studyCross-sectional survey✅ HCPs as subjects❌ No✅ SimpleShortLow⭐⭐⭐
40DTC pharmacogenomics testing awarenessCross-sectional survey✅ HCPs as subjects❌ No✅ SimpleShortLow⭐⭐⭐

Summary by Feasibility

RatingCountTopic Numbers
⭐⭐⭐ High181-5, 13, 15, 23, 24, 28, 29, 32, 33, 36, 37, 38, 39, 40
⭐⭐ Moderate128, 10, 11, 12, 14, 16, 17, 18, 20, 21, 27, 31, 35
⭐ Difficult106, 7, 9, 19, 22, 25, 26, 30, 34

Important Note for M. Pharm Students

Pharmacogenomics projects split into two types - choose based on your hospital's resources:
TypeExamplesRequiresFeasibility
Lab-based (wet lab)Topics 6-22, 25, 31Genotyping facility, PCR, high cost⭐ to ⭐⭐
Practice-based (no lab)Topics 1-5, 28, 29, 36-40Survey tools, hospital records only⭐⭐⭐
Record-based (existing data)Topics 13, 15, 23, 24, 32, 33Retrospective chart review⭐⭐⭐

Top 5 Picks (Feasible + High Impact)

#TopicWhy it Stands Out
1KAP of pharmacists on pharmacogenomicsNo lab needed, simple, very publishable in 2025-26
28Barriers to PGx implementation in hospitalsPolicy-relevant, survey-based, original for Indian settings
23HLA-B*15:02 screening and carbamazepine-SJSUses existing clinical test data, retrospective, high clinical impact
32G6PD screening before primaquineSimple enzyme assay, tropical disease relevance, feasible
37Patient perspectives on PGx testingTimely, patient-centered, easy survey design

Would you like me to now compile all topics from Cardiology, Gynecology, Neurology, Geriatrics, Oncology, and Pharmacogenomics into one master Excel file for easy download and comparison?

anyother?

Here are additional specialty areas for M. Pharm (Pharmacy Practice) project topics. Pick any one or more to explore:

🏥 Clinical Specialties

#SpecialtyKey Topics You Can Explore
1Nephrology / RenalDrug dose adjustment in CKD, nephrotoxic drug monitoring, dialysis drug dosing, medication adherence in transplant patients
2Pulmonology / RespiratoryInhaler technique assessment, COPD drug utilization, asthma pharmacotherapy, antibiotic stewardship in pneumonia
3Endocrinology / DiabetesInsulin adherence, glycemic control with pharmacist intervention, GLP-1/SGLT2 prescribing patterns, thyroid drug utilization
4Gastroenterology / HepatologyPPI overuse, drug-induced liver injury (DILI), IBD pharmacotherapy, antibiotic use in liver cirrhosis
5Infectious Diseases / HIVAntiretroviral adherence, TB-HIV co-infection drug monitoring, antibiotic stewardship, vaccine hesitancy
6PediatricsOff-label drug use in neonates, medication errors in pediatric ward, ADR monitoring in children, weight-based dose errors
7Orthopedics / RheumatologyNSAIDs/opioid use in chronic pain, DMARDs in rheumatoid arthritis, gout management audit, antibiotic prophylaxis in joint surgery
8DermatologyDrug-induced skin reactions, retinoid prescribing safety, topical corticosteroid misuse, antifungal prescribing patterns
9OphthalmologyDrug-induced ocular toxicity, glaucoma drug adherence, antibiotic prophylaxis in ophthalmic surgery
10Critical Care / ICUSedation and analgesia protocols, antibiotic de-escalation, medication errors in ICU, pharmacist role in critical care rounds

📋 Cross-Cutting Practice Domains

#DomainKey Topics You Can Explore
11Antibiotic StewardshipAMS program implementation, antibiotic audit, carbapenem use review, KAP of prescribers on AMR
12Medication SafetyHigh-alert medication practices, near-miss error reporting, look-alike/sound-alike (LASA) drugs, medication reconciliation
13Clinical Toxicology / PoisoningDrug overdose patterns, antidote utilization, self-poisoning drug profiles, pharmacist role in poison management
14PharmacoepidemiologyDisease burden studies, drug utilization trends, database studies using hospital data
15Digital Health / mHealthApp-based medication reminders, telepharmacy, patient portals, pharmacist perspectives on AI tools
16Community Pharmacy PracticeOTC drug counseling quality, self-medication practices, pharmacist-patient communication assessment
17Hospital Pharmacy ManagementDrug formulary management, procurement audits, storage compliance, expired drug analysis
18Patient Safety & QualityRoot cause analysis of medication incidents, pharmacist role in accreditation (NABH/JCI), sentinel event review

🔬 Emerging / Niche Areas (Novel for 2025-26)

#AreaWhy It's Trending
19Precision MedicineBiomarker-guided drug selection, companion diagnostics, PGx + clinical outcomes
20Medication Therapy Management (MTM)Pharmacist-led chronic disease management clinics, MTM models in Indian settings
21Palliative Care PharmacySymptom control audits, opioid access barriers, end-of-life medication use
22Mental Health PharmacyStigma and adherence in psychiatry, pharmacist role in de-stigmatization, clozapine monitoring
23Vaccine PharmacovigilancePost-vaccination ADR surveillance, HPV/COVID vaccine safety monitoring
24Green/Sustainable PharmacyPharmaceutical waste disposal, eco-pharmacovigilance, carbon footprint of drug use
25Telepharmacy / AI in PharmacyPharmacist attitudes toward AI prescribing support, telepharmacy feasibility in rural settings

Which of these interests you? Just name one (e.g., Nephrology, ICU, Antibiotic Stewardship, Diabetes) and I'll generate a full list of 40+ topics with a feasibility table - just like the previous ones.
Or if you're ready, I can now compile everything discussed so far into one master Excel file for download. Just say the word!

nephro, respiratory,endocrinology, infectious, pediatrics, ortho,dermatology,icu,gyneocology,cardiac

Reading File
Running Command

mkdir -p /home/daytona/workspace/mpharm-topics && echo "done"

Writing File

~/mpharm-topics/generate_topics.py

import openpyxl
from openpyxl.styles import (
    PatternFill, Font, Alignment, Border, Side
)
from openpyxl.utils import get_column_letter

# ── colour palette ──────────────────────────────────────────────────────────
HEADER_FILL   = PatternFill("solid", fgColor="1F4E79")   # dark navy
SUBHDR_FILL   = PatternFill("solid", fgColor="2E75B6")   # mid-blue
HIGH_FILL     = PatternFill("solid", fgColor="C6EFCE")   # green
MOD_FILL      = PatternFill("solid", fgColor="FFEB9C")   # yellow
LOW_FILL      = PatternFill("solid", fgColor="FFC7CE")   # red
ALT_FILL      = PatternFill("solid", fgColor="DEEAF1")   # light blue row
WHITE_FILL    = PatternFill("solid", fgColor="FFFFFF")

HEADER_FONT   = Font(name="Arial", bold=True, color="FFFFFF", size=11)
SUBHDR_FONT   = Font(name="Arial", bold=True, color="FFFFFF", size=10)
TITLE_FONT    = Font(name="Arial", bold=True, color="1F4E79", size=13)
BODY_FONT     = Font(name="Arial", size=10)
BOLD_FONT     = Font(name="Arial", bold=True, size=10)

thin = Side(style="thin", color="B8CCE4")
BORDER = Border(left=thin, right=thin, top=thin, bottom=thin)

COLUMNS = ["#", "Topic", "Category", "Study Type",
           "Data Access", "Lab/Special Equipment",
           "Ethics Complexity", "Time Required", "Cost",
           "Overall Feasibility"]

COL_WIDTHS = [4, 62, 22, 28, 22, 26, 20, 16, 10, 22]

# ── feasibility star helper ──────────────────────────────────────────────────
def stars(n):
    return "★" * n + "☆" * (3 - n)

def feas_fill(rating):
    if rating == 3: return HIGH_FILL
    if rating == 2: return MOD_FILL
    return LOW_FILL

# ── DATA ─────────────────────────────────────────────────────────────────────
# Each row: (topic, category, study_type, data_access, lab, ethics, time, cost, feasibility 1-3)

SPECIALTIES = {}

# ══════════════════════════════════════════════════════════════════════════════
SPECIALTIES["Nephrology"] = [
    ("Drug utilization study of drugs in CKD patients (stages 3-5)", "Drug Utilization", "Retrospective", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern of antihypertensives in CKD patients", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Drug dose adjustment assessment in CKD inpatients", "Drug Safety", "Retrospective/Prospective", "Easy – ward + lab records", "No", "Simple", "Medium", "Low", 3),
    ("Drug utilization review of erythropoiesis-stimulating agents in CKD", "Drug Utilization", "Retrospective", "Easy – ward/dialysis records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of nephrotoxic drug use in hospitalized patients", "Drug Safety", "Retrospective/Prospective", "Easy – case sheets + lab", "No", "Simple", "Medium", "Low", 3),
    ("Drug utilization of immunosuppressants in renal transplant patients", "Drug Utilization", "Retrospective", "Moderate – transplant records", "No", "Moderate", "Medium", "Low", 2),
    ("Medication adherence in CKD/dialysis patients (MMAS-8)", "Adherence", "Cross-sectional", "Easy – dialysis unit OPD", "No", "Simple", "Short", "Low", 3),
    ("Assessment of medication adherence in renal transplant patients", "Adherence", "Cross-sectional", "Easy – transplant OPD", "No", "Simple", "Short", "Low", 3),
    ("Impact of pharmacist counseling on adherence in CKD patients", "Adherence", "Prospective Interventional", "Easy – OPD patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("ADR monitoring of nephrotoxic drugs (NSAIDs, aminoglycosides, contrast)", "ADR/PV", "Prospective Observational", "Easy – ward patients", "No", "Simple", "Medium", "Low", 3),
    ("ADR profiling of immunosuppressants in transplant patients", "ADR/PV", "Prospective Observational", "Moderate – transplant unit", "No", "Moderate", "Long", "Low", 2),
    ("Contrast-induced nephropathy – incidence and risk factor assessment", "Drug Safety", "Prospective Observational", "Easy – radiology + nephro ward", "No", "Simple", "Medium", "Low", 3),
    ("Identification of DRPs in CKD inpatients using PCNE classification", "DRP", "Prospective Observational", "Easy – ward patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Drug-drug interactions in polypharmacy CKD patients", "DRP", "Retrospective/Prospective", "Easy – prescriptions", "No", "Simple", "Short", "Low", 3),
    ("Assessment of potassium-raising drug combinations in CKD patients", "Drug Safety", "Retrospective", "Easy – case records + labs", "No", "Simple", "Short", "Low", 3),
    ("Appropriateness of antibiotic dosing in CKD patients (renal dose adjustment)", "Medication Safety", "Retrospective", "Easy – ward records + eGFR", "No", "Simple", "Short", "Low", 3),
    ("Impact of pharmacist intervention on drug dose optimization in CKD", "Clinical Pharmacist", "Prospective Interventional", "Easy – ward patients", "No", "Moderate", "Medium", "Low", 3),
    ("Role of pharmacist in renal transplant medication management", "Clinical Pharmacist", "Prospective Observational", "Moderate – transplant OPD", "No", "Moderate", "Medium", "Low", 2),
    ("Assessment of calcium-phosphate balance and pharmacotherapy in dialysis patients", "Drug Utilization", "Cross-sectional", "Easy – dialysis unit records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of anemia management in CKD – iron, EPO, B12 use patterns", "Drug Utilization", "Retrospective", "Easy – dialysis/ward records", "No", "Simple", "Short", "Low", 3),
    ("KAP of CKD patients on dietary restrictions and medication use", "KAP", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Patient knowledge on dialysis-related medications and adherence", "KAP", "Cross-sectional Survey", "Easy – dialysis unit", "No", "Simple", "Short", "Low", 3),
    ("HRQoL in CKD/dialysis patients using KDQOL-SF", "QoL/Pharmaco-economics", "Cross-sectional", "Easy – dialysis unit OPD", "No", "Simple", "Short", "Low", 3),
    ("Cost-of-illness study of CKD in a tertiary care hospital", "Pharmaco-economics", "Retrospective", "Easy – hospital billing + records", "No", "Moderate", "Medium", "Low", 2),
    ("Pharmacoeconomic analysis of peritoneal vs. hemodialysis drug costs", "Pharmaco-economics", "Retrospective Comparative", "Moderate – dialysis records + billing", "No", "Moderate", "Medium", "Low", 2),
    ("Assessment of RAAS inhibitor use and outcomes in CKD patients", "Drug Utilization", "Retrospective", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of SGLT2 inhibitor prescribing in diabetic nephropathy", "Drug Utilization", "Retrospective/Cross-sectional", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Drug-induced acute kidney injury (AKI) – identification and assessment", "Drug Safety", "Prospective Observational", "Easy – ward + lab records", "No", "Simple", "Medium", "Low", 3),
    ("Assessment of proton pump inhibitor (PPI) overuse in CKD patients", "Drug Utilization", "Retrospective", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Medication reconciliation at dialysis initiation – discrepancy analysis", "Medication Safety", "Prospective Observational", "Easy – dialysis ward records", "No", "Moderate", "Medium", "Low", 3),
    ("Pharmacist role in phosphate binder counseling and adherence", "Clinical Pharmacist", "Prospective Interventional", "Easy – dialysis unit", "No", "Moderate", "Medium", "Low", 3),
    ("Assessment of vancomycin dosing in patients with renal impairment", "Drug Safety", "Retrospective", "Easy – ward + TDM records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of antibiotic stewardship in UTI/renal infection patients", "Antibiotic Stewardship", "Retrospective/Audit", "Easy – ward + microbiology records", "No", "Simple", "Short", "Low", 3),
    ("Sleep disorders and medication use in dialysis patients", "Drug Utilization", "Cross-sectional", "Easy – dialysis unit OPD", "No", "Simple", "Short", "Low", 3),
    ("Assessment of cardiovascular drug use in CKD patients – guideline adherence", "Drug Utilization", "Retrospective", "Easy – ward/OPD records", "No", "Simple", "Short", "Low", 3),
]

# ══════════════════════════════════════════════════════════════════════════════
SPECIALTIES["Respiratory"] = [
    ("Drug utilization study of bronchodilators in COPD patients", "Drug Utilization", "Retrospective", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern of inhaled corticosteroids (ICS) in asthma patients", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of inhaler technique in asthma/COPD patients", "Medication Safety", "Cross-sectional", "Easy – OPD patients (direct observation)", "No", "Simple", "Short", "Low", 3),
    ("Impact of pharmacist-led inhaler technique education on patient outcomes", "Clinical Pharmacist", "Prospective Interventional", "Easy – OPD patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Drug utilization review of antibiotics in community-acquired pneumonia (CAP)", "Drug Utilization/AMS", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of adherence to GOLD guidelines in COPD management", "Drug Utilization", "Retrospective/Audit", "Easy – ward/OPD records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern of antituberculosis drugs and adherence to RNTCP/NTEP", "Drug Utilization", "Retrospective", "Easy – DOTS records", "No", "Simple", "Short", "Low", 3),
    ("Medication adherence in asthma patients and associated factors (MMAS-8)", "Adherence", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Adherence to inhaler therapy in COPD and impact on exacerbations", "Adherence", "Prospective Observational", "Easy – OPD patients", "No", "Simple", "Medium", "Low", 3),
    ("ADR monitoring of antituberculosis drugs – incidence, pattern, causality", "ADR/PV", "Prospective Observational", "Easy – DOTS/TB ward patients", "No", "Simple", "Medium", "Low", 3),
    ("ADR profiling of inhaled corticosteroids and bronchodilators", "ADR/PV", "Prospective Observational", "Easy – OPD/ward patients", "No", "Simple", "Medium", "Low", 3),
    ("Drug-induced pulmonary toxicity surveillance in hospitalized patients", "ADR/PV", "Prospective Observational", "Easy – respiratory ward", "No", "Simple", "Medium", "Low", 3),
    ("Identification of DRPs in respiratory ward patients (PCNE classification)", "DRP", "Prospective Observational", "Easy – ward patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Drug-drug interactions in COPD/asthma polypharmacy patients", "DRP", "Retrospective/Prospective", "Easy – prescriptions", "No", "Simple", "Short", "Low", 3),
    ("Assessment of antibiotic stewardship in hospital-acquired pneumonia", "AMS", "Retrospective/Audit", "Easy – ward + micro records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of nebulization therapy practices in hospitalized patients", "Medication Safety", "Cross-sectional/Audit", "Easy – ward records/observation", "No", "Simple", "Short", "Low", 3),
    ("KAP of asthma patients on trigger avoidance and medication use", "KAP", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Assessment of patient knowledge on inhaler devices and spacer use", "KAP", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("HRQoL in COPD patients using St. George Respiratory Questionnaire (SGRQ)", "QoL", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("HRQoL in asthma patients using Asthma Quality of Life Questionnaire (AQLQ)", "QoL", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Cost-of-illness study of COPD exacerbations in a tertiary care hospital", "Pharmaco-economics", "Retrospective", "Easy – hospital billing + records", "No", "Moderate", "Medium", "Low", 2),
    ("Pharmacoeconomic analysis of generic vs. branded inhalers", "Pharmaco-economics", "Retrospective Comparative", "Easy – pharmacy records", "No", "Simple", "Short", "Low", 3),
    ("Impact of pharmacist counseling on self-management in COPD patients", "Clinical Pharmacist", "Prospective Interventional", "Easy – OPD patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Assessment of corticosteroid overuse in asthma management", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of step-up/step-down asthma therapy – GINA guideline adherence", "Drug Utilization", "Retrospective/Audit", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization of biologics (omalizumab, mepolizumab) in severe asthma", "Drug Utilization", "Retrospective", "Moderate – limited patient numbers", "No", "Simple", "Medium", "Low", 2),
    ("Assessment of COVID-19 related respiratory drug use patterns", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Pharmacist role in smoking cessation programs – counseling and NRT use", "Clinical Pharmacist", "Prospective Observational/Interventional", "Easy – OPD patients", "No", "Simple", "Medium", "Low", 3),
    ("Evaluation of oxygen therapy prescribing practices in COPD patients", "Medication Safety", "Retrospective/Audit", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of fixed-dose combination inhalers use vs. separate devices", "Drug Utilization", "Cross-sectional", "Easy – OPD/pharmacy records", "No", "Simple", "Short", "Low", 3),
    ("Medication reconciliation at discharge in respiratory inpatients", "Medication Safety", "Prospective Observational", "Easy – ward records", "No", "Moderate", "Medium", "Low", 3),
    ("Assessment of theophylline use and toxicity monitoring in COPD patients", "Drug Safety", "Retrospective/Prospective", "Easy – ward + TDM records", "No", "Simple", "Medium", "Low", 3),
    ("Antibiotic prescribing in acute exacerbation of COPD (AECOPD)", "AMS", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("KAP of healthcare providers on non-pharmacological management of asthma/COPD", "KAP", "Cross-sectional Survey", "Easy – HCPs as subjects", "No", "Simple", "Short", "Low", 3),
    ("Self-medication practices with OTC inhalers/bronchodilators in community", "Community Pharmacy", "Cross-sectional Survey", "Easy – community/OPD patients", "No", "Simple", "Short", "Low", 3),
]

# ══════════════════════════════════════════════════════════════════════════════
SPECIALTIES["Endocrinology"] = [
    ("Drug utilization study of antidiabetic drugs in Type 2 DM outpatients", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern of insulin in T1DM and T2DM inpatients", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of SGLT2 inhibitor and GLP-1 agonist prescribing patterns", "Drug Utilization", "Retrospective/Cross-sectional", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization review of thyroid drugs (levothyroxine) in hypothyroid patients", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern in gestational diabetes mellitus (GDM)", "Drug Utilization", "Retrospective/Prospective", "Easy – OPD/ward records", "No", "Simple", "Medium", "Low", 3),
    ("Assessment of drug use in polycystic ovarian syndrome (PCOS)", "Drug Utilization", "Cross-sectional/Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Medication adherence in Type 2 DM patients (MMAS-8) and glycemic control", "Adherence", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Impact of pharmacist counseling on HbA1c levels in T2DM patients", "Clinical Pharmacist", "Prospective Interventional", "Easy – OPD patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Adherence to insulin therapy and barriers in T1DM patients", "Adherence", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Adherence to antithyroid drugs in hyperthyroidism patients", "Adherence", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("ADR monitoring of antidiabetic drugs – hypoglycemia, GI effects, weight changes", "ADR/PV", "Prospective Observational", "Easy – OPD/ward patients", "No", "Simple", "Medium", "Low", 3),
    ("Drug-induced hyperglycemia surveillance in hospitalized patients", "ADR/PV", "Prospective Observational", "Easy – ward + lab records", "No", "Simple", "Medium", "Low", 3),
    ("ADR profiling of SGLT2 inhibitors – DKA, UTI, genital infections", "ADR/PV", "Prospective Observational", "Easy – OPD patients", "No", "Simple", "Medium", "Low", 3),
    ("Identification of DRPs in diabetic inpatients using PCNE classification", "DRP", "Prospective Observational", "Easy – ward patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Drug-drug interactions in polypharmacy diabetic patients", "DRP", "Retrospective/Prospective", "Easy – prescriptions", "No", "Simple", "Short", "Low", 3),
    ("Assessment of inappropriate medication use in elderly diabetic patients (Beers/STOPP)", "DRP", "Retrospective", "Easy – case records", "No", "Simple", "Short", "Low", 3),
    ("KAP of diabetic patients on blood glucose monitoring and insulin self-administration", "KAP", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Assessment of patient knowledge on hypoglycemia recognition and management", "KAP", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("KAP of hypothyroid patients on levothyroxine use and dietary interactions", "KAP", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("HRQoL in Type 2 DM patients using SF-36 / EQ-5D", "QoL", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("HRQoL in hypothyroid patients and impact of treatment", "QoL", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Cost-of-illness study of Type 2 diabetes mellitus in a tertiary care hospital", "Pharmaco-economics", "Retrospective", "Easy – hospital billing + records", "No", "Moderate", "Medium", "Low", 2),
    ("Pharmacoeconomic comparison of oral antidiabetic regimens vs. insulin", "Pharmaco-economics", "Retrospective Comparative", "Easy – pharmacy + billing records", "No", "Simple", "Medium", "Low", 3),
    ("Assessment of dyslipidemia management in diabetic patients – statin use patterns", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Pharmacist-led diabetes education program – impact on self-care behaviour", "Clinical Pharmacist", "Prospective Interventional", "Easy – OPD patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Evaluation of glycemic control in T2DM patients on combination therapy", "Clinical Outcomes", "Prospective Observational", "Easy – OPD records + HbA1c", "No", "Simple", "Medium", "Low", 3),
    ("Assessment of metformin use – appropriateness and contraindications", "Medication Safety", "Retrospective", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization of weight-loss medications in obese diabetic patients", "Drug Utilization", "Retrospective/Cross-sectional", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of diabetic complication screening and pharmacotherapy", "Clinical Outcomes", "Cross-sectional", "Easy – OPD patients + records", "No", "Simple", "Short", "Low", 3),
    ("Self-medication practices with OTC supplements in diabetic patients", "Community Pharmacy", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of insulin storage and handling practices in diabetic patients", "Medication Safety", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Pharmacist role in continuous glucose monitoring (CGM) education", "Clinical Pharmacist", "Prospective Observational", "Moderate – CGM device access", "No", "Moderate", "Medium", "Medium", 2),
    ("Assessment of prescribing in diabetic nephropathy – RAAS + SGLT2 combinations", "Drug Utilization", "Retrospective", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization of antiobesity drugs and pharmacist counseling role", "Drug Utilization", "Cross-sectional/Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of steroid-induced hyperglycemia management in hospitalized patients", "Drug Safety", "Prospective Observational", "Easy – ward + lab records", "No", "Simple", "Medium", "Low", 3),
]

# ══════════════════════════════════════════════════════════════════════════════
SPECIALTIES["Infectious Diseases"] = [
    ("Drug utilization study of antibiotics in a medicine/surgical ward (WHO DDD)", "Drug Utilization/AMS", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of antibiotic prescribing practices against standard guidelines (AWaRe)", "AMS", "Retrospective/Audit", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Antibiotic stewardship program (ASP) implementation and evaluation", "AMS", "Prospective Interventional", "Easy – ward records + micro", "No", "Moderate", "Medium", "Low", 3),
    ("Prescribing pattern of antiretrovirals (ART) in HIV patients – guideline adherence", "Drug Utilization", "Retrospective", "Easy – ART clinic records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization study of antifungal drugs in immunocompromised patients", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of antibiotic use in febrile neutropenia patients", "AMS", "Retrospective", "Easy – oncology ward records", "No", "Simple", "Short", "Low", 3),
    ("Medication adherence to ART in HIV patients (MMAS-8)", "Adherence", "Cross-sectional", "Easy – ART clinic patients", "No", "Simple", "Short", "Low", 3),
    ("Adherence to antituberculosis drugs and factors affecting it (DOTS patients)", "Adherence", "Cross-sectional Survey", "Easy – DOTS centre records", "No", "Simple", "Short", "Low", 3),
    ("Impact of pharmacist counseling on ART adherence and CD4 outcomes", "Clinical Pharmacist", "Prospective Interventional", "Easy – ART clinic", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("ADR monitoring and reporting in HIV/TB co-infected patients on HAART + ATT", "ADR/PV", "Prospective Observational", "Easy – HIV/TB ward patients", "No", "Simple", "Medium", "Low", 3),
    ("ADR profiling of first-line ART regimens in HIV patients", "ADR/PV", "Prospective Observational", "Easy – ART clinic patients", "No", "Simple", "Medium", "Low", 3),
    ("ADR monitoring of antituberculosis drugs – hepatotoxicity, peripheral neuropathy", "ADR/PV", "Prospective Observational", "Easy – TB ward/DOTS patients", "No", "Simple", "Medium", "Low", 3),
    ("Drug-induced liver injury (DILI) in patients on ATT – incidence and management", "Drug Safety", "Prospective Observational", "Easy – TB ward + LFT records", "No", "Simple", "Medium", "Low", 3),
    ("Drug-drug interactions in HIV patients on ART + co-medications", "DRP", "Retrospective/Prospective", "Easy – ART clinic prescriptions", "No", "Simple", "Short", "Low", 3),
    ("Identification of DRPs in infectious disease ward patients (PCNE)", "DRP", "Prospective Observational", "Easy – ward patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("KAP of patients on HIV/AIDS regarding ART adherence and drug interactions", "KAP", "Cross-sectional Survey", "Easy – ART clinic patients", "No", "Simple", "Short", "Low", 3),
    ("KAP of healthcare providers on antimicrobial resistance (AMR)", "KAP", "Cross-sectional Survey", "Easy – HCPs as subjects", "No", "Simple", "Short", "Low", 3),
    ("Assessment of blood culture utilisation and antibiotic de-escalation practices", "AMS", "Retrospective/Audit", "Easy – micro lab + ward records", "No", "Simple", "Short", "Low", 3),
    ("Carbapenem use audit in ICU/medicine ward – appropriateness assessment", "AMS", "Retrospective/Audit", "Easy – ward + pharmacy records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of antifungal prophylaxis in immunocompromised patients", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Cost-of-illness study of HIV/AIDS management in a tertiary care hospital", "Pharmaco-economics", "Retrospective", "Easy – hospital billing", "No", "Moderate", "Medium", "Low", 2),
    ("HRQoL in HIV patients on ART using SF-36/WHOQOL-BREF", "QoL", "Cross-sectional", "Easy – ART clinic patients", "No", "Simple", "Short", "Low", 3),
    ("Pharmacoeconomic impact of generic vs. innovator ART regimens", "Pharmaco-economics", "Retrospective Comparative", "Easy – pharmacy + billing records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of vaccination practices in HIV-positive patients", "Preventive Pharmacy", "Cross-sectional", "Easy – ART clinic records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of surgical antibiotic prophylaxis – appropriateness and duration", "AMS", "Retrospective/Audit", "Easy – OT + ward records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern of broad-spectrum antibiotics and culture sensitivity correlation", "AMS", "Retrospective", "Easy – micro lab + ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of anti-malarial drug use and adherence in malaria patients", "Drug Utilization", "Retrospective/Prospective", "Easy – ward/OPD records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization of antivirals in influenza/COVID-19 patients", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of medication errors related to antibiotic dosing and frequency", "Medication Safety", "Prospective Observational", "Easy – ward prescriptions", "No", "Moderate", "Medium", "Low", 2),
    ("Role of pharmacist in infection control and antimicrobial stewardship programs", "Clinical Pharmacist", "Prospective Observational", "Easy – ward/AMS team", "No", "Moderate", "Medium", "Low", 3),
    ("Assessment of drug resistance patterns and empirical antibiotic prescribing", "AMS", "Retrospective", "Easy – micro lab records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of antiviral therapy in Hepatitis B/C patients – guideline adherence", "Drug Utilization", "Retrospective", "Easy – hepatology/ID OPD records", "No", "Simple", "Short", "Low", 3),
    ("KAP on vaccine hesitancy among adults in a hospital setting", "KAP/Preventive", "Cross-sectional Survey", "Easy – OPD patients/staff", "No", "Simple", "Short", "Low", 3),
    ("Assessment of COVID-19 drug therapy and pharmacist interventions", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Self-medication with antibiotics – prevalence and awareness in community", "Community Pharmacy", "Cross-sectional Survey", "Easy – community patients", "No", "Simple", "Short", "Low", 3),
]

# ══════════════════════════════════════════════════════════════════════════════
SPECIALTIES["Pediatrics"] = [
    ("Drug utilization study in a pediatric inpatient ward", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of off-label drug use in neonatal ICU (NICU)", "Drug Utilization", "Retrospective", "Easy – NICU records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern of antibiotics in pediatric patients (WHO indicators)", "Drug Utilization/AMS", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of weight-based dose calculation errors in pediatric prescriptions", "Medication Safety", "Retrospective/Prospective", "Easy – ward prescriptions", "No", "Simple", "Medium", "Low", 3),
    ("Drug utilization review of antipyretics in febrile pediatric patients", "Drug Utilization", "Retrospective", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern in pediatric respiratory infections – antibiotic use assessment", "Drug Utilization/AMS", "Retrospective", "Easy – ward/OPD records", "No", "Simple", "Short", "Low", 3),
    ("Medication errors in pediatric ward – incidence, type, and contributing factors", "Medication Safety", "Prospective Observational", "Easy – ward records/observations", "No", "Moderate", "Medium", "Low", 2),
    ("ADR monitoring and reporting in hospitalized pediatric patients", "ADR/PV", "Prospective Observational", "Easy – ward patients", "No", "Simple", "Medium", "Low", 3),
    ("ADR profiling of antiepileptic drugs in pediatric epilepsy patients", "ADR/PV", "Prospective Observational", "Easy – neurology ward/OPD", "No", "Simple", "Medium", "Low", 3),
    ("Assessment of antibiotic prescribing in neonatal sepsis", "Drug Utilization/AMS", "Retrospective", "Easy – NICU records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization study of iron and vitamin supplements in pediatric patients", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of ORS and zinc use in pediatric diarrhea management", "Drug Utilization", "Retrospective/Prospective", "Easy – ward/OPD records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of vaccination coverage and pharmacist role in pediatric OPD", "Preventive Pharmacy", "Cross-sectional Survey", "Easy – OPD parents/patients", "No", "Simple", "Short", "Low", 3),
    ("Drug-drug interactions in polypharmacy pediatric inpatients", "DRP", "Retrospective/Prospective", "Easy – ward prescriptions", "No", "Simple", "Short", "Low", 3),
    ("Identification of DRPs in pediatric inpatients using PCNE classification", "DRP", "Prospective Observational", "Easy – ward patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Assessment of parental knowledge on correct antibiotic use in children", "KAP", "Cross-sectional Survey", "Easy – OPD parents", "No", "Simple", "Short", "Low", 3),
    ("KAP of parents on OTC drug use in fever and pain in children", "KAP", "Cross-sectional Survey", "Easy – OPD parents", "No", "Simple", "Short", "Low", 3),
    ("Assessment of pharmacist counseling impact on caregiver medication adherence in children", "Clinical Pharmacist", "Prospective Interventional", "Easy – OPD caregivers", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Evaluation of asthma pharmacotherapy in pediatric patients (GINA adherence)", "Drug Utilization", "Retrospective/Audit", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization in pediatric oncology patients – chemotherapy pattern study", "Drug Utilization", "Retrospective", "Moderate – oncology unit access", "No", "Moderate", "Medium", "Low", 2),
    ("Assessment of nutritional supplement prescribing in malnourished children", "Drug Utilization", "Retrospective", "Easy – ward/OPD records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of sedation and analgesia use in PICU patients", "Drug Utilization", "Retrospective", "Easy – PICU records", "No", "Simple", "Short", "Low", 3),
    ("HRQoL in children with chronic illness (asthma/epilepsy) using PedsQL", "QoL", "Cross-sectional", "Easy – OPD patients/parents", "No", "Simple", "Short", "Low", 3),
    ("Cost-of-illness study of pediatric respiratory infections", "Pharmaco-economics", "Retrospective", "Easy – hospital billing + records", "No", "Moderate", "Medium", "Low", 2),
    ("Assessment of rational drug use in pediatric OPD using WHO core indicators", "Drug Utilization", "Cross-sectional", "Easy – OPD prescriptions", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of pharmacist recommendations in pediatric ward rounds", "Clinical Pharmacist", "Prospective Observational", "Moderate – physician cooperation", "No", "Moderate", "Medium", "Low", 2),
    ("Drug-induced ADRs in pediatric patients on long-term therapy (TB, HIV, epilepsy)", "ADR/PV", "Prospective Observational", "Easy – ward/OPD patients", "No", "Simple", "Medium", "Low", 3),
    ("Prescription audit of pediatric inpatients using WHO prescribing indicators", "Drug Utilization", "Retrospective/Audit", "Easy – ward prescriptions", "No", "Simple", "Short", "Low", 3),
    ("Assessment of medication storage and handling practices by parents at home", "Medication Safety", "Cross-sectional Survey", "Easy – OPD parents", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of antipyretic and analgesic use patterns in pediatric emergency", "Drug Utilization", "Retrospective", "Easy – emergency records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization in children with type 1 diabetes – insulin patterns and monitoring", "Drug Utilization", "Retrospective/Prospective", "Easy – OPD/ward records", "No", "Simple", "Medium", "Low", 3),
    ("Assessment of fluid and electrolyte therapy in pediatric dehydration", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Role of pharmacist in pain management in pediatric palliative care", "Clinical Pharmacist", "Prospective Observational", "Moderate – palliative unit access", "No", "Moderate", "Medium", "Low", 2),
    ("Evaluation of antifungal use in immunocompromised pediatric patients", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of caregiver awareness on proper liquid medication measurement", "Medication Safety/KAP", "Cross-sectional Survey", "Easy – OPD caregivers", "No", "Simple", "Short", "Low", 3),
]

# ══════════════════════════════════════════════════════════════════════════════
SPECIALTIES["Orthopedics"] = [
    ("Drug utilization study of NSAIDs in orthopedic outpatients and inpatients", "Drug Utilization", "Retrospective", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of surgical antibiotic prophylaxis in orthopedic surgeries", "AMS", "Retrospective/Audit", "Easy – OT + ward records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern of analgesics in postoperative orthopedic patients", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of opioid use in chronic orthopedic pain management", "Drug Utilization", "Retrospective/Cross-sectional", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization review of disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis", "Drug Utilization", "Retrospective", "Easy – rheumatology OPD records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern of drugs in osteoarthritis management", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of calcium and vitamin D supplementation in osteoporosis patients", "Drug Utilization", "Retrospective/Cross-sectional", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Medication adherence in rheumatoid arthritis patients on DMARDs", "Adherence", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Adherence to bisphosphonate therapy in osteoporosis patients", "Adherence", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Impact of pharmacist counseling on NSAID-related GI risk awareness", "Clinical Pharmacist", "Prospective Interventional", "Easy – OPD patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("ADR monitoring of NSAIDs – GI, renal, and cardiovascular adverse effects", "ADR/PV", "Prospective Observational", "Easy – OPD/ward patients", "No", "Simple", "Medium", "Low", 3),
    ("ADR profiling of DMARDs (methotrexate, sulfasalazine, hydroxychloroquine)", "ADR/PV", "Prospective Observational", "Easy – rheumatology OPD", "No", "Simple", "Medium", "Low", 3),
    ("Drug-induced GI complications in patients on long-term NSAIDs – assessment and PPI use", "Drug Safety", "Retrospective/Prospective", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of anticoagulant use in deep vein thrombosis (DVT) prophylaxis post-orthopedic surgery", "Drug Utilization", "Retrospective", "Easy – OT/ward records", "No", "Simple", "Short", "Low", 3),
    ("Drug-drug interactions in polypharmacy rheumatology patients", "DRP", "Retrospective/Prospective", "Easy – OPD prescriptions", "No", "Simple", "Short", "Low", 3),
    ("Identification of DRPs in orthopedic inpatients using PCNE classification", "DRP", "Prospective Observational", "Easy – ward patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Assessment of inappropriate NSAID use in elderly orthopedic patients (Beers/STOPP)", "DRP", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("KAP of rheumatoid arthritis patients on methotrexate – side effects and monitoring", "KAP", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Assessment of patient knowledge on bisphosphonate correct administration technique", "KAP", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("KAP of patients on self-medication with NSAIDs for musculoskeletal pain", "KAP", "Cross-sectional Survey", "Easy – OPD/community patients", "No", "Simple", "Short", "Low", 3),
    ("HRQoL in rheumatoid arthritis patients using HAQ-DI / SF-36", "QoL", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("HRQoL in osteoarthritis patients before and after pharmacological intervention", "QoL", "Prospective", "Easy – OPD patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Cost-of-illness study of rheumatoid arthritis in a tertiary care hospital", "Pharmaco-economics", "Retrospective", "Easy – hospital billing + records", "No", "Moderate", "Medium", "Low", 2),
    ("Pharmacoeconomic analysis of biologic vs. conventional DMARDs in RA", "Pharmaco-economics", "Retrospective Comparative", "Moderate – limited biologic patients", "No", "Moderate", "Medium", "Low", 2),
    ("Evaluation of uric acid-lowering therapy in gout – allopurinol/febuxostat use", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Drug use in ankylosing spondylitis – NSAIDs, DMARDs, biologic patterns", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of pain management protocols in total knee/hip replacement patients", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Medication reconciliation at discharge in orthopedic inpatients", "Medication Safety", "Prospective Observational", "Easy – ward records", "No", "Moderate", "Medium", "Low", 3),
    ("Assessment of steroid use in orthopedic conditions – patterns and complications", "Drug Utilization", "Retrospective", "Easy – ward/OPD records", "No", "Simple", "Short", "Low", 3),
    ("Role of pharmacist in fall prevention in elderly orthopedic patients (FRIDs)", "Clinical Pharmacist", "Prospective Observational", "Easy – ward patients", "No", "Moderate", "Medium", "Low", 3),
    ("Drug utilization of muscle relaxants in musculoskeletal disorders", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of corticosteroid injection practices in orthopedic OPD", "Drug Utilization", "Retrospective/Audit", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of physiotherapy vs. pharmacotherapy in chronic low back pain patients", "Clinical Outcomes", "Retrospective Comparative", "Easy – OPD records", "No", "Simple", "Medium", "Low", 3),
    ("KAP of orthopedic patients on antibiotic prophylaxis before dental/surgical procedures", "KAP", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Assessment of topical vs. systemic NSAID prescribing in musculoskeletal pain", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
]

# ══════════════════════════════════════════════════════════════════════════════
SPECIALTIES["Dermatology"] = [
    ("Drug utilization study of topical corticosteroids in dermatology outpatients", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of topical corticosteroid misuse/overuse in skin conditions", "Medication Safety", "Cross-sectional/Retrospective", "Easy – OPD patients/records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern of antifungals in superficial fungal infections", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization review of systemic retinoids (isotretinoin) in acne management", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("ADR monitoring of isotretinoin therapy – teratogenicity risk, mood changes, lipid effects", "ADR/PV", "Prospective Observational", "Easy – dermatology OPD patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Drug-induced skin reactions (DISR) – incidence, pattern, and causality assessment", "ADR/PV", "Prospective Observational", "Easy – ward/OPD patients", "No", "Simple", "Medium", "Low", 3),
    ("Stevens-Johnson Syndrome (SJS/TEN) – drug causality analysis and pharmacist role", "ADR/PV", "Retrospective", "Easy – dermatology ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of antibiotic prescribing in skin and soft tissue infections (SSTIs)", "AMS", "Retrospective/Audit", "Easy – ward/OPD records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization study of biologics (dupilumab, secukinumab) in psoriasis/atopic dermatitis", "Drug Utilization", "Retrospective", "Moderate – limited patient numbers", "No", "Simple", "Medium", "Low", 2),
    ("Prescribing pattern of antileprosy drugs and adherence in leprosy patients", "Drug Utilization", "Retrospective", "Easy – leprosy clinic records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of medication adherence in psoriasis patients on systemic therapy", "Adherence", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Adherence to topical therapy in eczema/atopic dermatitis patients", "Adherence", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Impact of pharmacist counseling on proper use of topical medications", "Clinical Pharmacist", "Prospective Interventional", "Easy – OPD patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Assessment of drug interactions in dermatology polypharmacy patients", "DRP", "Retrospective/Prospective", "Easy – OPD prescriptions", "No", "Simple", "Short", "Low", 3),
    ("Identification of DRPs in dermatology inpatients using PCNE classification", "DRP", "Prospective Observational", "Easy – ward patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("KAP of dermatology patients on topical steroid use and side effects", "KAP", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Patient awareness of photoprotection and sunscreen pharmacotherapy", "KAP", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Assessment of OTC drug use and self-medication in skin conditions", "Community Pharmacy", "Cross-sectional Survey", "Easy – OPD/community patients", "No", "Simple", "Short", "Low", 3),
    ("HRQoL in psoriasis patients using DLQI (Dermatology Life Quality Index)", "QoL", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("HRQoL in acne patients using DLQI and impact of pharmacotherapy", "QoL", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Cost-of-illness study of psoriasis in a tertiary care hospital", "Pharmaco-economics", "Retrospective", "Easy – hospital billing + records", "No", "Moderate", "Medium", "Low", 2),
    ("Pharmacoeconomic comparison of topical vs. systemic acne therapies", "Pharmaco-economics", "Retrospective Comparative", "Easy – pharmacy + billing records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization of antihistamines in allergic skin conditions", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of methotrexate use and toxicity monitoring in psoriasis/pemphigus", "Drug Safety", "Prospective Observational", "Easy – OPD patients + LFT/CBC", "No", "Simple", "Medium", "Low", 3),
    ("Evaluation of antivirals (acyclovir/valacyclovir) prescribing in herpes infections", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing patterns in urticaria management – antihistamines and steroids", "Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of scabies and pediculosis treatment practices and outcomes", "Drug Utilization", "Retrospective/Cross-sectional", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of cyclosporine use in dermatological conditions – safety monitoring", "Drug Safety", "Prospective Observational", "Easy – OPD patients + lab records", "No", "Moderate", "Medium", "Low", 2),
    ("Drug utilization of dapsone in dermatological conditions – safety monitoring", "Drug Safety/Drug Utilization", "Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of phototherapy drug prescribing (PUVA/NB-UVB) in psoriasis", "Drug Utilization", "Retrospective/Audit", "Easy – phototherapy unit records", "No", "Simple", "Short", "Low", 3),
    ("KAP of pharmacists on dermatology OTC products and counseling", "KAP", "Cross-sectional Survey", "Easy – pharmacists as subjects", "No", "Simple", "Short", "Low", 3),
    ("Drug-induced alopecia – identification, causality, and pharmacist reporting", "ADR/PV", "Prospective Observational", "Easy – OPD patients", "No", "Simple", "Medium", "Low", 3),
    ("Assessment of wound care and antimicrobial dressing use in dermatology ward", "Drug Utilization", "Retrospective/Audit", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of sunscreen prescribing and patient compliance in photodermatoses", "Drug Utilization/Adherence", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Medication reconciliation in dermatology inpatients at admission and discharge", "Medication Safety", "Prospective Observational", "Easy – ward records", "No", "Moderate", "Medium", "Low", 3),
]

# ══════════════════════════════════════════════════════════════════════════════
SPECIALTIES["ICU"] = [
    ("Drug utilization study of antibiotics in ICU patients (WHO DDD methodology)", "Drug Utilization/AMS", "Retrospective", "Easy – ICU records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of carbapenem use in ICU – appropriateness and antibiotic stewardship", "AMS", "Retrospective/Audit", "Easy – ICU + micro records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization review of sedatives and analgesics (ABCDE bundle adherence)", "Drug Utilization", "Retrospective", "Easy – ICU records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern of vasopressors and inotropes in septic shock patients", "Drug Utilization", "Retrospective", "Easy – ICU case records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of anticoagulant use (DVT prophylaxis) in ICU patients", "Drug Utilization", "Retrospective", "Easy – ICU records", "No", "Simple", "Short", "Low", 3),
    ("Drug dose adjustment in acute kidney injury (AKI) ICU patients", "Drug Safety", "Retrospective", "Easy – ICU + lab records", "No", "Simple", "Short", "Low", 3),
    ("ADR monitoring in ICU patients – incidence, type, and clinical impact", "ADR/PV", "Prospective Observational", "Easy – ICU ward patients", "No", "Simple", "Medium", "Low", 3),
    ("Drug-induced QT prolongation in ICU patients – monitoring and assessment", "ADR/PV", "Prospective Observational", "Easy – ICU + ECG records", "No", "Moderate", "Medium", "Low", 3),
    ("Medication errors in ICU – incidence, type, severity, and contributing factors", "Medication Safety", "Prospective Observational", "Moderate – staff cooperation needed", "No", "Moderate", "Medium", "Low", 2),
    ("Assessment of high-alert medication (HAM) safety practices in ICU", "Medication Safety", "Cross-sectional/Audit", "Easy – ICU pharmacy/ward", "No", "Simple", "Short", "Low", 3),
    ("Drug-drug interactions in polypharmacy ICU patients – prevalence and clinical significance", "DRP", "Retrospective/Prospective", "Easy – ICU prescriptions", "No", "Simple", "Short", "Low", 3),
    ("Identification of DRPs in ICU patients using PCNE classification", "DRP", "Prospective Observational", "Easy – ICU patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Assessment of stress ulcer prophylaxis (PPI/H2RA) appropriateness in ICU", "Drug Utilization", "Retrospective/Audit", "Easy – ICU records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of blood glucose management and insulin protocol adherence in ICU", "Drug Safety/Utilization", "Retrospective/Prospective", "Easy – ICU + lab records", "No", "Simple", "Medium", "Low", 3),
    ("Assessment of nutrition (TPN/enteral) drug interactions in ICU patients", "Drug Safety", "Prospective Observational", "Easy – ICU records", "No", "Simple", "Medium", "Low", 3),
    ("Role of clinical pharmacist in ICU ward rounds – types and outcomes of interventions", "Clinical Pharmacist", "Prospective Observational", "Moderate – physician cooperation", "No", "Moderate", "Medium", "Low", 2),
    ("Impact of pharmacist-led medication review on ICU drug-related problems", "Clinical Pharmacist", "Prospective Interventional", "Easy – ICU patients", "No", "Moderate", "Medium", "Low", 3),
    ("Pharmacist participation in antimicrobial stewardship in ICU – outcomes", "Clinical Pharmacist/AMS", "Prospective Observational", "Easy – ICU/AMS team", "No", "Moderate", "Medium", "Low", 3),
    ("Assessment of neuromuscular blocking agent (NMBA) use in mechanically ventilated patients", "Drug Utilization", "Retrospective", "Easy – ICU records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization of proton pump inhibitors and H2 blockers in ICU – overuse analysis", "Drug Utilization", "Retrospective/Audit", "Easy – ICU records", "No", "Simple", "Short", "Low", 3),
    ("Evaluation of opioid use and sedation scoring (RASS) adherence in ventilated ICU patients", "Drug Utilization", "Retrospective", "Easy – ICU records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of antimicrobial de-escalation practices in ICU", "AMS", "Retrospective", "Easy – ICU + micro records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization of thromboprophylaxis in post-surgical ICU patients", "Drug Utilization", "Retrospective", "Easy – ICU ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of vancomycin TDM practices in ICU patients", "Drug Safety", "Retrospective/Prospective", "Easy – ICU + TDM lab records", "No", "Simple", "Medium", "Low", 3),
    ("Evaluation of nephrotoxic drug combinations in ICU patients", "Drug Safety", "Retrospective", "Easy – ICU + lab records", "No", "Simple", "Short", "Low", 3),
    ("KAP of ICU nurses and physicians on medication error reporting", "KAP", "Cross-sectional Survey", "Easy – ICU staff as subjects", "No", "Simple", "Short", "Low", 3),
    ("Pharmacoeconomic analysis of generic vs. branded ICU drugs", "Pharmaco-economics", "Retrospective Comparative", "Easy – ICU pharmacy records", "No", "Simple", "Short", "Low", 3),
    ("Cost of antibiotic resistance in ICU patients – economic burden study", "Pharmaco-economics", "Retrospective", "Easy – hospital billing + micro records", "No", "Moderate", "Medium", "Low", 2),
    ("Assessment of propofol infusion syndrome (PRIS) risk monitoring in ICU", "Drug Safety", "Prospective Observational", "Easy – ICU patients on propofol", "No", "Simple", "Medium", "Low", 3),
    ("Evaluation of glycopeptide (vancomycin/teicoplanin) use in ICU – dose adequacy", "Drug Utilization/AMS", "Retrospective", "Easy – ICU + lab records", "No", "Simple", "Short", "Low", 3),
    ("Drug-induced electrolyte disturbances in ICU patients – monitoring assessment", "Drug Safety", "Prospective Observational", "Easy – ICU + lab records", "No", "Simple", "Medium", "Low", 3),
    ("Assessment of medication reconciliation in ICU patients at admission/discharge", "Medication Safety", "Prospective Observational", "Easy – ICU records", "No", "Moderate", "Medium", "Low", 3),
    ("Evaluation of delirium management pharmacotherapy in ICU (PADIS guidelines)", "Drug Utilization", "Retrospective/Audit", "Easy – ICU records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization of antifungals in ICU patients – prophylaxis vs. treatment patterns", "Drug Utilization/AMS", "Retrospective", "Easy – ICU records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of pharmacist-led medication error prevention strategies in ICU", "Clinical Pharmacist/Medication Safety", "Prospective Interventional", "Moderate – multidisciplinary cooperation", "No", "Moderate", "Long", "Low", 2),
]

# ══════════════════════════════════════════════════════════════════════════════
SPECIALTIES["Gynecology"] = [
    ("Drug utilization study in antenatal care (ANC) – iron, folic acid, calcium prescribing", "Drug Utilization", "Retrospective", "Easy – ANC OPD records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern of oxytocics and uterotonics in labour and delivery ward", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization review in postpartum hemorrhage (PPH) management", "Drug Utilization", "Retrospective", "Easy – case sheets", "No", "Simple", "Short", "Low", 3),
    ("Assessment of antibiotic prescribing in caesarean section – appropriateness", "AMS", "Retrospective/Audit", "Easy – OT + ward records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization study in gestational diabetes mellitus (GDM)", "Drug Utilization", "Retrospective/Prospective", "Easy – OPD/ward records", "No", "Simple", "Medium", "Low", 3),
    ("Adherence to iron and folic acid supplementation in pregnant women", "Adherence", "Cross-sectional", "Easy – ANC clinic patients", "No", "Simple", "Short", "Low", 3),
    ("Compliance with antihypertensives in pregnancy-induced hypertension (PIH)/preeclampsia", "Adherence", "Prospective Observational", "Easy – ward + OPD", "No", "Simple", "Medium", "Low", 3),
    ("Adherence in PCOS patients on metformin/OCP and associated factors", "Adherence", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Impact of pharmacist counseling on adherence to antenatal supplements", "Clinical Pharmacist", "Prospective Interventional", "Easy – ANC clinic", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("ADR monitoring of obstetric drugs – oxytocin, magnesium sulfate, misoprostol", "ADR/PV", "Prospective Observational", "Easy – ward patients", "No", "Simple", "Medium", "Low", 3),
    ("ADR surveillance of hormonal contraceptives in family planning clinic", "ADR/PV", "Cross-sectional/Prospective", "Easy – family planning OPD", "No", "Simple", "Medium", "Low", 3),
    ("Teratogenicity risk assessment – category C/D/X drug exposure in first trimester", "Drug Safety", "Retrospective", "Moderate – detailed records needed", "No", "Moderate", "Medium", "Low", 2),
    ("ADR profiling in preeclampsia – labetalol, nifedipine, magnesium sulfate", "ADR/PV", "Prospective Observational", "Easy – ward patients", "No", "Simple", "Medium", "Low", 3),
    ("Identification of DRPs in high-risk pregnancy patients (PCNE classification)", "DRP", "Prospective Observational", "Easy – high-risk OPD/ward", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Drug-drug interactions in polypharmacy obstetric patients", "DRP", "Retrospective/Prospective", "Easy – prescriptions/case sheets", "No", "Simple", "Short", "Low", 3),
    ("Inappropriate medication use in pregnancy (FDA/Hale lactation risk analysis)", "Drug Safety", "Retrospective", "Easy – case records", "No", "Simple", "Short", "Low", 3),
    ("Medication errors in obstetric wards – types, factors, and pharmacist interventions", "Medication Safety", "Prospective Observational", "Moderate – staff cooperation needed", "No", "Moderate", "Medium", "Low", 2),
    ("Impact of pharmacist counseling on nausea and vomiting of pregnancy (NVP)", "Clinical Pharmacist", "Prospective Interventional", "Easy – ANC OPD", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Pharmacist role in preeclampsia drug therapy optimization", "Clinical Pharmacist", "Prospective Interventional", "Easy – ward patients", "No", "Moderate", "Medium", "Low", 2),
    ("Pharmacist interventions reducing medication errors in L&D unit", "Medication Safety", "Prospective Interventional", "Moderate – ward access needed", "No", "Moderate", "Long", "Medium", 2),
    ("Pharmacist recommendations in gynecology ward rounds – type and acceptance", "Clinical Pharmacist", "Prospective Observational", "Moderate – physician cooperation", "No", "Moderate", "Medium", "Low", 2),
    ("KAP on oral contraceptive pill (OCP) use among reproductive-age women", "KAP", "Cross-sectional Survey", "Easy – OPD/community women", "No", "Simple", "Short", "Low", 3),
    ("Patient knowledge on drugs in pregnancy and lactation", "KAP", "Cross-sectional Survey", "Easy – ANC/postnatal patients", "No", "Simple", "Short", "Low", 3),
    ("Patient awareness of emergency contraception", "KAP", "Cross-sectional Survey", "Easy – OPD/community", "No", "Simple", "Short", "Low", 3),
    ("KAP of self-medication in pregnant women – risks and prevalence", "KAP", "Cross-sectional Survey", "Easy – ANC OPD", "No", "Simple", "Short", "Low", 3),
    ("Cost-of-illness study of preeclampsia in a tertiary care setting", "Pharmaco-economics", "Retrospective/Prospective", "Easy – hospital billing + records", "No", "Moderate", "Medium", "Low", 2),
    ("Pharmacoeconomic comparison of misoprostol vs. oxytocin in PPH prevention", "Pharmaco-economics", "Retrospective Comparative", "Easy – ward records + billing", "No", "Simple", "Medium", "Low", 3),
    ("Direct medical costs associated with gestational diabetes management", "Pharmaco-economics", "Retrospective", "Easy – hospital billing", "No", "Simple", "Short", "Low", 3),
    ("HRQoL in PCOS women using SF-36 questionnaire", "QoL", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Pharmacotherapy assessment in PCOS – ovulation induction, metformin, OCP", "Drug Utilization", "Cross-sectional/Retrospective", "Easy – OPD records", "No", "Simple", "Short", "Low", 3),
    ("Drug therapy evaluation in endometriosis – hormonal and analgesic patterns", "Drug Utilization", "Retrospective", "Moderate – diagnosis confirmation", "No", "Simple", "Medium", "Low", 2),
    ("Management of preterm labor – tocolytic drug use assessment and outcomes", "Drug Utilization", "Retrospective/Prospective", "Easy – ward records", "No", "Simple", "Medium", "Low", 3),
    ("Chemotherapy regimen safety monitoring in gynecological cancers", "Drug Safety", "Prospective Observational", "Moderate – oncology unit access", "No", "Moderate", "Long", "Medium", 2),
    ("Antifungal use in vulvovaginal candidiasis – OTC vs. prescription analysis", "Drug Utilization", "Cross-sectional/Retrospective", "Easy – OPD records/pharmacy", "No", "Simple", "Short", "Low", 3),
    ("Pharmacist role in reproductive health counseling – contraception and preconception", "Clinical Pharmacist", "Cross-sectional/Interventional", "Easy – OPD patients", "No", "Simple", "Medium", "Low", 3),
    ("Assessment of pharmacist knowledge on drugs in breastfeeding", "KAP", "Cross-sectional Survey", "Easy – pharmacists as subjects", "No", "Simple", "Short", "Low", 3),
    ("Progesterone supplementation in threatened abortion – prescribing and outcomes", "Drug Utilization", "Retrospective Observational", "Easy – case records", "No", "Simple", "Short", "Low", 3),
    ("Digital health interventions for antenatal medication adherence", "Emerging Topics", "Prospective Interventional", "Moderate – smartphone access needed", "No", "Moderate", "Long", "Medium", 2),
    ("Evaluation of IV vs. oral iron therapy in pregnancy-related anemia", "Clinical Outcomes", "Prospective Comparative", "Easy – ANC ward/OPD", "No", "Moderate (IV access)", "Medium", "Medium", 3),
]

# ══════════════════════════════════════════════════════════════════════════════
SPECIALTIES["Cardiology"] = [
    ("Drug utilization study of antihypertensives in hypertensive inpatients/outpatients (WHO DDD)", "Drug Utilization", "Retrospective", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern of antiplatelet agents in ACS patients", "Drug Utilization", "Retrospective", "Easy – ward records", "No", "Simple", "Short", "Low", 3),
    ("Assessment of statin prescribing and LDL goal attainment in CAD patients", "Drug Utilization", "Retrospective/Prospective", "Easy – OPD/ward records", "No", "Simple", "Short", "Low", 3),
    ("Drug utilization review of anticoagulants in atrial fibrillation patients", "Drug Utilization", "Retrospective", "Easy – ward/OPD records", "No", "Simple", "Short", "Low", 3),
    ("Prescribing pattern in heart failure – adherence to GDMT guidelines", "Drug Utilization", "Retrospective/Audit", "Easy – ward/OPD records", "No", "Simple", "Short", "Low", 3),
    ("Medication adherence in hypertensive patients (MMAS-8) and associated factors", "Adherence", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Adherence to DAPT post-PCI/stent and clinical outcomes", "Adherence", "Prospective Observational", "Easy – cardiology OPD", "No", "Simple", "Medium", "Low", 3),
    ("Impact of pharmacist counseling on medication adherence and BP control", "Clinical Pharmacist", "Prospective Interventional", "Easy – OPD patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Factors influencing non-adherence to statin therapy in dyslipidemia patients", "Adherence", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("DRPs in cardiac ICU patients using PCNE classification", "DRP", "Prospective Observational", "Easy – CICU patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Drug-drug interactions in polypharmacy cardiac patients – prevalence/significance", "DRP", "Cross-sectional/Retrospective", "Easy – OPD/ward prescriptions", "No", "Simple", "Short", "Low", 3),
    ("Clinical significance of DDIs in patients on warfarin – pharmacist impact", "DRP", "Prospective Observational", "Easy – anticoagulation clinic", "No", "Simple", "Medium", "Low", 3),
    ("Inappropriate prescribing in elderly cardiac patients (Beers/STOPP-START)", "DRP", "Retrospective", "Easy – case records", "No", "Simple", "Short", "Low", 3),
    ("ADR monitoring of cardiovascular drugs – ACE inhibitors, statins, amiodarone, digoxin", "ADR/PV", "Prospective Observational", "Easy – cardiology ward", "No", "Simple", "Medium", "Low", 3),
    ("Statin-induced myopathy surveillance – incidence, risk factors, pharmacist reporting", "ADR/PV", "Prospective Observational", "Easy – OPD patients", "No", "Simple", "Medium", "Low", 3),
    ("ADR profiling of antiarrhythmic drugs – prospective observational study", "ADR/PV", "Prospective Observational", "Easy – ward/OPD patients", "No", "Simple", "Medium", "Low", 3),
    ("Causality and severity assessment of ADRs in cardiac patients (Naranjo + WHO-UMC)", "ADR/PV", "Prospective Observational", "Easy – ward patients", "No", "Simple", "Medium", "Low", 3),
    ("Impact of pharmacist-led medication review on DRPs in heart failure patients", "Clinical Pharmacist", "Prospective Interventional", "Easy – HF clinic patients", "No", "Moderate", "Medium", "Low", 3),
    ("Pharmacist interventions in improving INR control in warfarin patients", "Clinical Pharmacist", "Prospective Observational", "Easy – anticoagulation clinic", "No", "Simple", "Medium", "Low", 3),
    ("Role of clinical pharmacist in anticoagulation management clinic", "Clinical Pharmacist", "Prospective Observational", "Easy – anticoagulation clinic", "No", "Simple", "Medium", "Low", 3),
    ("Pharmacist-driven hypertension management program – BP control and QoL", "Clinical Pharmacist", "Prospective Interventional", "Easy – OPD patients", "No", "Moderate (consent)", "Medium", "Low", 3),
    ("Assessment of pharmacist recommendations in cardiology ward rounds", "Clinical Pharmacist", "Prospective Observational", "Moderate – physician cooperation", "No", "Moderate", "Medium", "Low", 2),
    ("Cost-of-illness study of heart failure in a tertiary care cardiology unit", "Pharmaco-economics", "Retrospective", "Easy – hospital billing + records", "No", "Moderate", "Medium", "Low", 2),
    ("Pharmacoeconomic analysis of thrombolytic therapy vs. primary PCI in STEMI", "Pharmaco-economics", "Retrospective Comparative", "Easy – ward + billing records", "No", "Moderate", "Medium", "Low", 2),
    ("Cost-effectiveness of generic vs. branded antihypertensives", "Pharmaco-economics", "Retrospective Comparative", "Easy – pharmacy records", "No", "Simple", "Short", "Low", 3),
    ("KAP of hypertensive patients on their disease and medication", "KAP", "Cross-sectional Survey", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Impact of pharmacist-led cardiac rehab counseling on lifestyle modification", "Clinical Pharmacist", "Prospective Interventional", "Easy – cardiac rehab patients", "No", "Moderate", "Medium", "Low", 3),
    ("HRQoL in heart failure patients using MLHFQ (Minnesota Living with HF)", "QoL", "Cross-sectional", "Easy – OPD patients", "No", "Simple", "Short", "Low", 3),
    ("Patient knowledge on anticoagulation therapy and pharmacist education impact", "KAP/Clinical Pharmacist", "Cross-sectional + Interventional", "Easy – OPD patients", "No", "Simple", "Medium", "Low", 3),
    ("Medication errors in cardiology ICU – incidence, type, contributing factors", "Medication Safety", "Prospective Observational", "Moderate – staff cooperation", "No", "Moderate", "Medium", "Low", 2),
    ("High-alert medication safety assessment in cardiac care unit", "Medication Safety", "Cross-sectional/Audit", "Easy – ward/pharmacy records", "No", "Simple", "Short", "Low", 3),
    ("Medication reconciliation in cardiac inpatients at admission and discharge", "Medication Safety", "Prospective Observational", "Easy – ward records", "No", "Moderate", "Medium", "Low", 3),
    ("Assessment of SGLT2 inhibitor prescribing for cardiovascular risk reduction in T2DM", "Drug Utilization", "Retrospective/Cross-sectional", "Easy – cardiology/endo OPD records", "No", "Simple", "Short", "Low", 3),
    ("Pharmacist role in managing polypharmacy in chronic heart failure – deprescribing", "Clinical Pharmacist", "Prospective Interventional", "Easy – HF clinic patients", "No", "Moderate", "Medium", "Low", 3),
    ("Evaluation of antibiotic prophylaxis practices in cardiac surgery", "AMS", "Retrospective/Audit", "Easy – OT + ward records", "No", "Simple", "Short", "Low", 3),
]

# ══════════════════════════════════════════════════════════════════════════════

def write_specialty_sheet(wb, name, rows):
    ws = wb.create_sheet(title=name[:31])  # Excel max 31 chars

    # Title row
    ws.merge_cells("A1:J1")
    title_cell = ws["A1"]
    title_cell.value = f"M. Pharm (Pharmacy Practice) – {name} Project Topics"
    title_cell.font = TITLE_FONT
    title_cell.alignment = Alignment(horizontal="center", vertical="center")
    title_cell.fill = WHITE_FILL
    ws.row_dimensions[1].height = 22

    # Header row
    for col_idx, col_name in enumerate(COLUMNS, start=1):
        cell = ws.cell(row=2, column=col_idx, value=col_name)
        cell.font = HEADER_FONT
        cell.fill = HEADER_FILL
        cell.alignment = Alignment(horizontal="center", vertical="center", wrap_text=True)
        cell.border = BORDER
    ws.row_dimensions[2].height = 30

    # Data rows
    current_cat = None
    row_num = 3
    for idx, (topic, cat, study_type, data_access, lab, ethics, time_req, cost, feasibility) in enumerate(rows, start=1):
        # Category sub-header
        if cat != current_cat:
            current_cat = cat
            ws.merge_cells(f"A{row_num}:J{row_num}")
            cat_cell = ws.cell(row=row_num, column=1, value=f"  {cat}")
            cat_cell.font = SUBHDR_FONT
            cat_cell.fill = SUBHDR_FILL
            cat_cell.alignment = Alignment(horizontal="left", vertical="center")
            cat_cell.border = BORDER
            ws.row_dimensions[row_num].height = 18
            row_num += 1

        fill = ALT_FILL if idx % 2 == 0 else WHITE_FILL
        star_text = stars(feasibility)
        fstar_fill = feas_fill(feasibility)

        values = [idx, topic, cat, study_type, data_access, lab, ethics, time_req, cost, star_text]
        for col_idx, val in enumerate(values, start=1):
            cell = ws.cell(row=row_num, column=col_idx, value=val)
            cell.font = BODY_FONT
            cell.alignment = Alignment(vertical="center", wrap_text=True,
                                       horizontal="center" if col_idx != 2 else "left")
            cell.border = BORDER
            if col_idx == 10:
                cell.fill = fstar_fill
                cell.font = Font(name="Arial", bold=True, size=10)
            else:
                cell.fill = fill
        ws.row_dimensions[row_num].height = 36
        row_num += 1

    # Column widths
    for col_idx, width in enumerate(COL_WIDTHS, start=1):
        ws.column_dimensions[get_column_letter(col_idx)].width = width

    # Freeze panes
    ws.freeze_panes = "A3"

    # Summary block
    row_num += 1
    ws.merge_cells(f"A{row_num}:J{row_num}")
    sum_title = ws.cell(row=row_num, column=1, value="FEASIBILITY SUMMARY")
    sum_title.font = Font(name="Arial", bold=True, size=11, color="1F4E79")
    sum_title.alignment = Alignment(horizontal="center")
    row_num += 1

    high = sum(1 for r in rows if r[-1] == 3)
    mod  = sum(1 for r in rows if r[-1] == 2)
    low  = sum(1 for r in rows if r[-1] == 1)

    for label, count, fill_c in [
        ("★★★ High Feasibility", high, HIGH_FILL),
        ("★★ Moderate Feasibility", mod, MOD_FILL),
        ("★ Difficult", low, LOW_FILL),
    ]:
        ws.merge_cells(f"A{row_num}:I{row_num}")
        lc = ws.cell(row=row_num, column=1, value=label)
        lc.font = BOLD_FONT
        lc.fill = fill_c
        lc.alignment = Alignment(horizontal="left", vertical="center")
        cc = ws.cell(row=row_num, column=10, value=count)
        cc.font = BOLD_FONT
        cc.fill = fill_c
        cc.alignment = Alignment(horizontal="center")
        ws.row_dimensions[row_num].height = 18
        row_num += 1


def main():
    wb = openpyxl.Workbook()
    # Remove default sheet
    wb.remove(wb.active)

    # ── INDEX sheet ──────────────────────────────────────────────────────────
    idx_ws = wb.create_sheet(title="INDEX", index=0)
    idx_ws.merge_cells("A1:D1")
    t = idx_ws["A1"]
    t.value = "M. Pharm (Pharmacy Practice) – Master Topic List"
    t.font = Font(name="Arial", bold=True, size=14, color="1F4E79")
    t.alignment = Alignment(horizontal="center", vertical="center")
    idx_ws.row_dimensions[1].height = 28

    headers = ["#", "Specialty", "Total Topics", "High Feasibility (★★★)"]
    for ci, h in enumerate(headers, 1):
        c = idx_ws.cell(row=2, column=ci, value=h)
        c.font = HEADER_FONT
        c.fill = HEADER_FILL
        c.alignment = Alignment(horizontal="center", vertical="center")
        c.border = BORDER
    idx_ws.row_dimensions[2].height = 22

    for si, (spec, rows) in enumerate(SPECIALTIES.items(), start=1):
        high = sum(1 for r in rows if r[-1] == 3)
        row_data = [si, spec, len(rows), high]
        for ci, val in enumerate(row_data, 1):
            c = idx_ws.cell(row=si + 2, column=ci, value=val)
            c.font = BODY_FONT
            c.fill = ALT_FILL if si % 2 == 0 else WHITE_FILL
            c.alignment = Alignment(horizontal="center", vertical="center")
            c.border = BORDER
        idx_ws.row_dimensions[si + 2].height = 18

    for ci, w in enumerate([5, 30, 16, 26], 1):
        idx_ws.column_dimensions[get_column_letter(ci)].width = w

    # ── speciality sheets ────────────────────────────────────────────────────
    for spec, rows in SPECIALTIES.items():
        write_specialty_sheet(wb, spec, rows)

    out_path = "/home/daytona/workspace/mpharm-topics/MPharm_Pharmacy_Practice_Topics.xlsx"
    wb.save(out_path)
    print(f"Saved: {out_path}")

main()
Running Command

cd /home/daytona/workspace/mpharm-topics && python generate_topics.py 2>&1

Running Command

python3 -c " import openpyxl, tempfile, shutil wb = openpyxl.Workbook() ws = wb.active ws['A1'] = 'test' tmp = tempfile.mktemp(suffix='.xlsx') wb.save(tmp) shutil.move(tmp, '/home/daytona/workspace/mpharm-topics/test.xlsx') print('ok', tmp) "

Running Command

# Try writing directly using a BytesIO buffer then write bytes to file python3 -c " import openpyxl, io wb = openpyxl.Workbook() ws = wb.active ws['A1'] = 'test' buf = io.BytesIO() wb.save(buf) buf.seek(0) with open('/home/daytona/workspace/mpharm-topics/test.xlsx', 'wb') as f: f.write(buf.read()) print('ok') "

Editing File

~/mpharm-topics/generate_topics.py

Successfully replaced 1 instance(s) of the string in '/home/daytona/workspace/mpharm-topics/generate_topics.py'
Running Command

cd /home/daytona/workspace/mpharm-topics && python generate_topics.py 2>&1

Running Command

ls -lh /home/daytona/workspace/mpharm-topics/MPharm_Pharmacy_Practice_Topics.xlsx

Your master Excel file is ready! Here's a summary of what's inside:

MPharm Pharmacy Practice Topics

Spreadsheet · XLSX


What's in the File

SheetSpecialtyTopics
INDEXOverview of all specialties-
NephrologyRenal/CKD/Dialysis/Transplant35
RespiratoryAsthma/COPD/TB/Pneumonia35
EndocrinologyDiabetes/Thyroid/PCOS/Obesity35
Infectious DiseasesHIV/TB/AMS/Antivirals/Vaccines35
PediatricsNeonates/Children/Off-label/Errors35
OrthopedicsNSAIDs/DMARDs/Osteoporosis/Gout35
DermatologyTopical steroids/Retinoids/Psoriasis35
ICUSedation/AMS/Medication errors/High-alert35
GynecologyANC/Contraception/Preeclampsia/PPH39
CardiologyHypertension/ACS/HF/Anticoagulation35
Total: 354 topics across 10 specialties

Each Topic Includes:

  • Category (Drug Utilization, ADR/PV, Adherence, DRP, Clinical Pharmacist, KAP, QoL, Pharmaco-economics, AMS, Medication Safety)
  • Study Type (Retrospective, Cross-sectional, Prospective Interventional, etc.)
  • Data Access difficulty
  • Lab/Special Equipment needed (Yes/No)
  • Ethics Complexity
  • Time Required (Short/Medium/Long)
  • Cost (Low/Medium/High)
  • Overall Feasibility (★★★ / ★★ / ★) - color coded green/yellow/red

Download the Excel file and filter by feasibility (★★★ = easiest for 2-year M. Pharm)

Running Command

python3 -c " import openpyxl wb = openpyxl.load_workbook('/home/daytona/workspace/mpharm-topics/MPharm_Pharmacy_Practice_Topics.xlsx') print('Sheets:', wb.sheetnames) # Peek at first data sheet ws = wb['Nephrology'] for row in ws.iter_rows(min_row=1, max_row=5, values_only=True): print(row) "

Writing File

~/mpharm-topics/filter_topics.py

import openpyxl, io
from openpyxl.styles import PatternFill, Font, Alignment, Border, Side
from openpyxl.utils import get_column_letter

# ── styles ───────────────────────────────────────────────────────────────────
HEADER_FILL  = PatternFill("solid", fgColor="1F4E79")
TITLE_FILL   = PatternFill("solid", fgColor="E2EFDA")   # soft green for ★★★ theme
HIGH_FILL    = PatternFill("solid", fgColor="C6EFCE")
ALT_FILL     = PatternFill("solid", fgColor="F0FFF0")   # very light green alt row
WHITE_FILL   = PatternFill("solid", fgColor="FFFFFF")
SPEC_FILL    = PatternFill("solid", fgColor="375623")   # dark green for specialty header
SUBHDR_FILL  = PatternFill("solid", fgColor="548235")   # medium green sub-header

HEADER_FONT  = Font(name="Arial", bold=True, color="FFFFFF", size=11)
TITLE_FONT   = Font(name="Arial", bold=True, color="375623", size=13)
BODY_FONT    = Font(name="Arial", size=10)
BOLD_FONT    = Font(name="Arial", bold=True, size=10)
SPEC_FONT    = Font(name="Arial", bold=True, color="FFFFFF", size=11)

thin = Side(style="thin", color="A9D18E")
BORDER = Border(left=thin, right=thin, top=thin, bottom=thin)

SPECIALTY_SHEETS = ['Nephrology','Respiratory','Endocrinology','Infectious Diseases',
                    'Pediatrics','Orthopedics','Dermatology','ICU','Gynecology','Cardiology']

COLUMNS = ["#", "Topic", "Category", "Study Type",
           "Data Access", "Lab Required",
           "Ethics", "Time", "Cost", "Feasibility"]

COL_WIDTHS = [4, 64, 22, 28, 26, 14, 18, 12, 8, 14]

def apply_header(ws, row, values, fill, font):
    for ci, val in enumerate(values, 1):
        c = ws.cell(row=row, column=ci, value=val)
        c.font = font
        c.fill = fill
        c.alignment = Alignment(horizontal="center", vertical="center", wrap_text=True)
        c.border = BORDER
    ws.row_dimensions[row].height = 28

def write_data_row(ws, row_num, idx, data, alt):
    fill = ALT_FILL if alt else WHITE_FILL
    for ci, val in enumerate([idx] + list(data), 1):
        c = ws.cell(row=row_num, column=ci, value=val)
        c.font = BODY_FONT
        c.fill = fill
        c.alignment = Alignment(vertical="center", wrap_text=True,
                                horizontal="left" if ci == 2 else "center")
        c.border = BORDER
        if ci == 10:  # feasibility column
            c.fill = HIGH_FILL
            c.font = BOLD_FONT
    ws.row_dimensions[row_num].height = 38

def set_col_widths(ws):
    for ci, w in enumerate(COL_WIDTHS, 1):
        ws.column_dimensions[get_column_letter(ci)].width = w

# ── read source workbook ──────────────────────────────────────────────────────
src_wb = openpyxl.load_workbook('/home/daytona/workspace/mpharm-topics/MPharm_Pharmacy_Practice_Topics.xlsx')

# Extract ★★★ rows per specialty
specialty_data = {}   # {specialty: [(topic, cat, study_type, data_access, lab, ethics, time, cost, feas), ...]}

for spec in SPECIALTY_SHEETS:
    ws = src_wb[spec]
    rows = []
    for row in ws.iter_rows(min_row=3, values_only=True):
        # Skip merged category sub-headers (col B onward is None)
        if row[1] is None:
            continue
        # Only keep ★★★
        if row[9] == '★★★':
            # (topic, cat, study_type, data_access, lab, ethics, time, cost, feas)
            rows.append((row[1], row[2], row[3], row[4], row[5], row[6], row[7], row[8], row[9]))
    specialty_data[spec] = rows

# ── build new workbook ────────────────────────────────────────────────────────
wb = openpyxl.Workbook()
wb.remove(wb.active)

# ── MASTER COMBINED sheet ─────────────────────────────────────────────────────
master = wb.create_sheet(title="ALL ★★★ Topics", index=0)

# Title
master.merge_cells("A1:J1")
t = master["A1"]
t.value = "M. Pharm (Pharmacy Practice) – All ★★★ High Feasibility Topics (Filtered)"
t.font = TITLE_FONT
t.fill = TITLE_FILL
t.alignment = Alignment(horizontal="center", vertical="center")
master.row_dimensions[1].height = 24

apply_header(master, 2, COLUMNS, HEADER_FILL, HEADER_FONT)
master.freeze_panes = "A3"

master_row = 3
global_idx = 1

for spec in SPECIALTY_SHEETS:
    rows = specialty_data[spec]
    if not rows:
        continue
    # Specialty divider row
    master.merge_cells(f"A{master_row}:J{master_row}")
    sc = master.cell(row=master_row, column=1, value=f"  {spec.upper()}  ({len(rows)} topics)")
    sc.font = SPEC_FONT
    sc.fill = SPEC_FILL
    sc.alignment = Alignment(horizontal="left", vertical="center")
    sc.border = BORDER
    master.row_dimensions[master_row].height = 20
    master_row += 1

    for alt_idx, row_data in enumerate(rows):
        write_data_row(master, master_row, global_idx, row_data, alt_idx % 2 == 1)
        global_idx += 1
        master_row += 1

set_col_widths(master)

# Summary row
master_row += 1
master.merge_cells(f"A{master_row}:I{master_row}")
s = master.cell(row=master_row, column=1, value=f"TOTAL ★★★ Topics")
s.font = BOLD_FONT
s.fill = HIGH_FILL
s.alignment = Alignment(horizontal="left")
c = master.cell(row=master_row, column=10, value=global_idx - 1)
c.font = BOLD_FONT
c.fill = HIGH_FILL
c.alignment = Alignment(horizontal="center")
master.row_dimensions[master_row].height = 18

# ── per-specialty sheets ──────────────────────────────────────────────────────
for spec in SPECIALTY_SHEETS:
    rows = specialty_data[spec]
    ws = wb.create_sheet(title=spec[:31])

    # Title
    ws.merge_cells("A1:J1")
    t = ws["A1"]
    t.value = f"★★★ High Feasibility Topics – {spec}"
    t.font = TITLE_FONT
    t.fill = TITLE_FILL
    t.alignment = Alignment(horizontal="center", vertical="center")
    ws.row_dimensions[1].height = 24

    apply_header(ws, 2, COLUMNS, HEADER_FILL, HEADER_FONT)
    ws.freeze_panes = "A3"

    current_cat = None
    row_num = 3
    alt_toggle = 0

    for idx, row_data in enumerate(rows, 1):
        cat = row_data[1]
        if cat != current_cat:
            current_cat = cat
            ws.merge_cells(f"A{row_num}:J{row_num}")
            cc = ws.cell(row=row_num, column=1, value=f"  {cat}")
            cc.font = Font(name="Arial", bold=True, color="FFFFFF", size=10)
            cc.fill = SUBHDR_FILL
            cc.alignment = Alignment(horizontal="left", vertical="center")
            cc.border = BORDER
            ws.row_dimensions[row_num].height = 18
            row_num += 1
            alt_toggle = 0

        write_data_row(ws, row_num, idx, row_data, alt_toggle % 2 == 1)
        alt_toggle += 1
        row_num += 1

    set_col_widths(ws)

    # Count summary at bottom
    row_num += 1
    ws.merge_cells(f"A{row_num}:I{row_num}")
    s = ws.cell(row=row_num, column=1,
                value=f"Total ★★★ topics in {spec}: {len(rows)}  (all suitable for 2-year M. Pharm)")
    s.font = BOLD_FONT
    s.fill = HIGH_FILL
    s.alignment = Alignment(horizontal="left")
    ws.row_dimensions[row_num].height = 18

# ── INDEX sheet ───────────────────────────────────────────────────────────────
idx_ws = wb.create_sheet(title="INDEX", index=1)
idx_ws.merge_cells("A1:D1")
t = idx_ws["A1"]
t.value = "M. Pharm (Pharmacy Practice) – ★★★ Filtered Master Index"
t.font = TITLE_FONT
t.fill = TITLE_FILL
t.alignment = Alignment(horizontal="center", vertical="center")
idx_ws.row_dimensions[1].height = 24

for ci, h in enumerate(["#", "Specialty", "★★★ Topics", "% of Total"], 1):
    c = idx_ws.cell(row=2, column=ci, value=h)
    c.font = HEADER_FONT
    c.fill = HEADER_FILL
    c.alignment = Alignment(horizontal="center", vertical="center")
    c.border = BORDER
idx_ws.row_dimensions[2].height = 22

src_totals = {}
for spec in SPECIALTY_SHEETS:
    ws_src = src_wb[spec]
    total = sum(1 for r in ws_src.iter_rows(min_row=3, values_only=True) if r[1] is not None)
    src_totals[spec] = total

for si, spec in enumerate(SPECIALTY_SHEETS, 1):
    high = len(specialty_data[spec])
    total = src_totals[spec]
    pct = f"{round(high/total*100)}%" if total else "-"
    for ci, val in enumerate([si, spec, high, pct], 1):
        c = idx_ws.cell(row=si + 2, column=ci, value=val)
        c.font = BODY_FONT
        c.fill = ALT_FILL if si % 2 == 0 else WHITE_FILL
        c.alignment = Alignment(horizontal="center", vertical="center")
        c.border = BORDER
    idx_ws.row_dimensions[si + 2].height = 18

# Totals row
tr = len(SPECIALTY_SHEETS) + 3
for ci, val in enumerate(["", "TOTAL", sum(len(specialty_data[s]) for s in SPECIALTY_SHEETS), ""], 1):
    c = idx_ws.cell(row=tr, column=ci, value=val)
    c.font = BOLD_FONT
    c.fill = HIGH_FILL
    c.alignment = Alignment(horizontal="center")
    c.border = BORDER
idx_ws.row_dimensions[tr].height = 18

for ci, w in enumerate([5, 30, 16, 12], 1):
    idx_ws.column_dimensions[get_column_letter(ci)].width = w

# ── save ──────────────────────────────────────────────────────────────────────
out_path = "/home/daytona/workspace/mpharm-topics/MPharm_HighFeasibility_Topics_Filtered.xlsx"
buf = io.BytesIO()
wb.save(buf)
buf.seek(0)
with open(out_path, "wb") as f:
    f.write(buf.read())
print(f"Saved: {out_path}")
print(f"Total ★★★ topics: {global_idx - 1}")
for spec in SPECIALTY_SHEETS:
    print(f"  {spec}: {len(specialty_data[spec])}")
Running Command

cd /home/daytona/workspace/mpharm-topics && python filter_topics.py 2>&1

Your filtered file is ready for download:

MPharm HighFeasibility Topics Filtered

Spreadsheet · XLSX


What's inside

SheetContents
ALL ★★★ TopicsEvery high-feasibility topic from all 10 specialties in one scrollable list
INDEXSummary table - specialty, topic count, % filtered
Nephrology30 ★★★ topics
Respiratory33 ★★★ topics
Endocrinology33 ★★★ topics
Infectious Diseases33 ★★★ topics
Pediatrics30 ★★★ topics
Orthopedics33 ★★★ topics
Dermatology32 ★★★ topics
ICU31 ★★★ topics
Gynecology30 ★★★ topics
Cardiology31 ★★★ topics
TOTAL316 topics

What was filtered OUT (★★ / ★)

Topics excluded typically involved:
  • Genotyping / lab-based work (pharmacogenomics)
  • Limited patient pool (rare diseases, biologics, immunotherapy)
  • Need for community follow-up or long discharge tracking
  • Heavy physician/MDT cooperation requirements
  • Very long timelines (>9 months) or high cost
All 316 remaining topics are doable within a 2-year M. Pharm with standard hospital access, low cost, and straightforward ethics approval. Would you like a study protocol for any specific topic?
This is a shared conversation. Sign in to Orris to start your own chat.